
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Updating understanding of real-world adverse events associated with omeprazole - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="1525463C8AF3276305463C002CF48D91.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="plosone">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367145/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="PLOS One">
<meta name="citation_title" content="Updating understanding of real-world adverse events associated with omeprazole">
<meta name="citation_author" content="Jijun Zhang">
<meta name="citation_author_institution" content="Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China">
<meta name="citation_author_institution" content="Department of General Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China">
<meta name="citation_author" content="Jie An">
<meta name="citation_author_institution" content="Department of General Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China">
<meta name="citation_publication_date" content="2025 Aug 20">
<meta name="citation_volume" content="20">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e0330509">
<meta name="citation_doi" content="10.1371/journal.pone.0330509">
<meta name="citation_pmid" content="40834017">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367145/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367145/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367145/pdf/pone.0330509.pdf">
<meta name="description" content="This study aims to assess the adverse events (AEs) and safety profile of omeprazole, a widely used proton pump inhibitor (PPI) for acid-related diseases. Despite being a first-line treatment, its overuse due to easy accessibility and lack of public ...">
<meta name="og:title" content="Updating understanding of real-world adverse events associated with omeprazole">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="This study aims to assess the adverse events (AEs) and safety profile of omeprazole, a widely used proton pump inhibitor (PPI) for acid-related diseases. Despite being a first-line treatment, its overuse due to easy accessibility and lack of public ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367145/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12367145">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1371/journal.pone.0330509"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/pone.0330509.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12367145%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12367145/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12367145/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367145/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-plosone.png" alt="PLOS One logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to PLOS One" title="Link to PLOS One" shape="default" href="https://doi.org/10.1371/journal.pone.0330509" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">PLoS One</button></div>. 2025 Aug 20;20(8):e0330509. doi: <a href="https://doi.org/10.1371/journal.pone.0330509" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0330509</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22PLoS%20One%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PLoS%20One%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Updating understanding of real-world adverse events associated with omeprazole</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Jijun Zhang</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Jijun Zhang</span></h3>
<div class="p">
<sup>1</sup>Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China</div>
<div class="p">
<sup>2</sup>Department of General Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China</div>
<div>Conceptualization, Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jijun Zhang</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22An%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Jie An</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Jie An</span></h3>
<div class="p">
<sup>2</sup>Department of General Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China</div>
<div>Conceptualization, Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22An%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jie An</span></a>
</div>
</div>
<sup>2,</sup><sup>*</sup>
</div>
<div class="cg p">Editor: <span class="name western">Satish Rojekar</span><sup>3</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff001">
<sup>1</sup>Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China</div>
<div id="aff002">
<sup>2</sup>Department of General Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China</div>
<div id="edit1">
<sup>3</sup>Icahn School of Medicine at Mount Sinai Department of Pharmacological Sciences, UNITED STATES OF AMERICA</div>
<div class="author-notes p">
<div class="fn" id="coi001"><p><strong>Competing Interests: </strong>All the authors of this study declare that there is no conflict of interest.</p></div>
<div class="fn" id="cor001">
<sup>✉</sup><p class="display-inline">* E-mail: <span>anjie@sxbqeh.com.cn</span></p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Jijun Zhang</span></strong>: <span class="role">Conceptualization, Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Jie An</span></strong>: <span class="role">Conceptualization, Data curation</span>
</div>
<div class="p">
<strong class="contrib"><span class="name western">Satish Rojekar</span></strong>: <span class="role">Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 May 27; Accepted 2025 Aug 1; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 Zhang, An</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12367145  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40834017/" class="usa-link">40834017</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec001"><h3 class="pmc_sec_title">Background</h3>
<p>This study aims to assess the adverse events (AEs) and safety profile of omeprazole, a widely used proton pump inhibitor (PPI) for acid-related diseases. Despite being a first-line treatment, its overuse due to easy accessibility and lack of public awareness about usage guidelines may lead to potential side effects, necessitating a reassessment of its safety.</p></section><section id="sec002"><h3 class="pmc_sec_title">Methods</h3>
<p>We extracted 119,159 adverse event reports (AERs) related to omeprazole from the FDA Adverse Event Reporting System (FAERS) database, covering data from Q1 2004 to Q4 2023. A disproportionality analysis was performed to evaluate indications, concomitant medication use, and safety.</p></section><section id="sec003"><h3 class="pmc_sec_title">Results</h3>
<p>Omeprazole was commonly prescribed for gastroesophageal reflux disease (GERD), dyspepsia, peptic ulcers, and gastritis. It was frequently used with drugs like aspirin, lisinopril, furosemide, atorvastatin, and metoprolol. Notably, renal and urinary disorders showed strong positive signals, including chronic kidney disease, acute kidney injury, and renal failure, with statistically significant disproportionality measures. The study also identified adverse reactions not listed on drug labels, such as hyperparathyroidism secondary and intentional product misuse.</p></section><section id="sec004"><h3 class="pmc_sec_title">Conclusions</h3>
<p>Our findings provide new insights into the safety of omeprazole in real-world clinical settings, highlighting novel adverse events and offering evidence for safer clinical use.</p></section></section><section id="sec005"><h2 class="pmc_sec_title">Introduction</h2>
<p>Peptic ulcer and gastroesophageal reflux disease are both the most common digestive disorders. Peptic ulcers, which occur mainly in the stomach and proximal duodenum, are acidic, digestive injuries to the muscular layer of the mucosa and deeper tissues of the digestive tract caused by a combination of stomach acid and pepsin [<a href="#pone.0330509.ref001" class="usa-link" aria-describedby="pone.0330509.ref001">1</a>]. The lifetime prevalence of peptic ulcers is around 5–12% [<a href="#pone.0330509.ref002" class="usa-link" aria-describedby="pone.0330509.ref002">2</a>,<a href="#pone.0330509.ref003" class="usa-link" aria-describedby="pone.0330509.ref003">3</a>]. In the United States, over 500,000 people are diagnosed with peptic ulcers annually, which places a significant burden on the public health system and government finances [<a href="#pone.0330509.ref004" class="usa-link" aria-describedby="pone.0330509.ref004">4</a>]. Gastroesophageal reflux disease (GERD) is a condition characterized by the reflux of stomach acid into the esophagus, of which acid reflux and heartburn are the most typical clinical symptoms [<a href="#pone.0330509.ref005" class="usa-link" aria-describedby="pone.0330509.ref005">5</a>,<a href="#pone.0330509.ref006" class="usa-link" aria-describedby="pone.0330509.ref006">6</a>]. The prevalence of GERD varies slightly across different countries and regions. In the United States, the prevalence of GERD ranges from approximately 6% to 30%, while in China, it ranges from approximately 2.5% to 29.8% [<a href="#pone.0330509.ref007" class="usa-link" aria-describedby="pone.0330509.ref007">7</a>]. Proton pump inhibitors (PPIs) and histamine 2 receptor antagonists (H2RAs), two common acid-suppressing drugs, are widely used in the treatment of peptic ulcers and GERD and have been found to be highly effective in clinical practice [<a href="#pone.0330509.ref008" class="usa-link" aria-describedby="pone.0330509.ref008">8</a>–<a href="#pone.0330509.ref010" class="usa-link" aria-describedby="pone.0330509.ref010">10</a>].</p>
<p>Omeprazole, a commonly utilized PPI, selectively inhibits the activity of H + /K + ATPase in gastric parietal cells, effectively suppressing gastric acid secretion [<a href="#pone.0330509.ref011" class="usa-link" aria-describedby="pone.0330509.ref011">11</a>]. Over the past two decades, PPIs have progressively superseded H2RAs as the first-line therapy for acid suppression due to their remarkable acid-inhibitory effects. However, the ease of accessibility of PPIs and the public’s inadequate awareness of their usage restrictions have contributed to the increasingly prominent phenomenon of overuse [<a href="#pone.0330509.ref012" class="usa-link" aria-describedby="pone.0330509.ref012">12</a>], which has sparked widespread concern and apprehension. In a retrospective study conducted in China, researchers conducted an in-depth analysis of up to 25,850 prescription records, revealing an alarming number of 13,589 prescriptions involving inappropriate prescribing of PPIs, particularly omeprazole [<a href="#pone.0330509.ref013" class="usa-link" aria-describedby="pone.0330509.ref013">13</a>]. This finding underscores the urgent need for standardizing the use of PPIs and reducing unnecessary prescriptions. Furthermore, numerous studies have corroborated that prolonged and inappropriate use of omeprazole significantly elevates the risk of a myriad of adverse events (AEs) spanning multiple organ systems [<a href="#pone.0330509.ref014" class="usa-link" aria-describedby="pone.0330509.ref014">14</a>–<a href="#pone.0330509.ref017" class="usa-link" aria-describedby="pone.0330509.ref017">17</a>]. These risks encompass, but are not limited to, electrolyte imbalances such as hyponatremia [<a href="#pone.0330509.ref014" class="usa-link" aria-describedby="pone.0330509.ref014">14</a>], skeletal health issues including osteoporosis and heightened fracture risk [<a href="#pone.0330509.ref015" class="usa-link" aria-describedby="pone.0330509.ref015">15</a>,<a href="#pone.0330509.ref016" class="usa-link" aria-describedby="pone.0330509.ref016">16</a>], as well as renal impairment and an increased incidence of chronic kidney disease [<a href="#pone.0330509.ref017" class="usa-link" aria-describedby="pone.0330509.ref017">17</a>]. Consequently, the rational and prudent use of omeprazole is of paramount importance in ensuring patient safety and mitigating medical risks.</p>
<p>The study analyzed AERs related to omeprazole in the FDA Adverse Event Reporting System (FAERS) database using multiple metrics in Disproportionality Analysis (DPA) to explore potential adverse drug reactions (ADRs) signals in a real-world setting.</p></section><section id="sec006"><h2 class="pmc_sec_title">Methods</h2>
<section id="sec007"><h3 class="pmc_sec_title">Sources of omeprazole data</h3>
<p>The FAERS (the FDA Adverse Event Reporting System) database was released by the U. S. Food and Drug Administration (FDA) in 2004. Its primary purpose is to collect and analyze AERs for drugs and biologics. The data is updated quarterly to monitor drug safety and identify potential risks to protect public health. This study utilized publicly available anonymized data from the FAERS database. As the data does not contain identifiable information and the research does not involve direct interaction with human participants, ethics approval and informed consent were not required.</p>
<p>Based on the time to market of omeprazole, this retrospective drug safety study downloaded the data on omeprazole-related adverse reactions from the first quarter of 2004 to the fourth quarter of 2023 (a total of 80 quarters) and analyzed the data using R software 4.3.3 and Excel.</p></section><section id="sec008"><h3 class="pmc_sec_title">Standardization and extraction of omeprazole data</h3>
<p>Reports listing omeprazole as the primary suspect drug were included. To ensure data accuracy and uniqueness, the following FDA-recommended deduplication criteria were applied: (1) Extract the PRIMARYID, CASEID, and FDA_DT fields from the DEMO table of the FAERS database. (2) When CASEID are the same, select the most recent FDA_DT; (3) When both CASEID and FDA_DT are identical, select the PRIMARYID with larger numerical values [<a href="#pone.0330509.ref018" class="usa-link" aria-describedby="pone.0330509.ref018">18</a>]. Drug names underwent standardization through the application of the Medex_UIMA_1.3.8 system, a natural language processing-based tool specifically engineered to extract and normalize medication information from unstructured textual data, thereby mitigating variability in the reporting of drug nomenclature [<a href="#pone.0330509.ref019" class="usa-link" aria-describedby="pone.0330509.ref019">19</a>]. MedDRA (Medical Dictionary for Regulatory Activities), serving as a standardized medical terminology system, primarily functions to classify adverse event information. This system maps each individual adverse event to its corresponding Preferred Term (PT) and System Organ Class (SOC). In the present study, we employed MedDRA version 25.0 to conduct the classification of adverse events, ensuring that each adverse event was accurately mapped to its respective PT and the associated SOC [<a href="#pone.0330509.ref020" class="usa-link" aria-describedby="pone.0330509.ref020">20</a>]. Despite the excellent performance of these tools, Medex UIMA 1.3.8 may misclassify due to text ambiguity, and inconsistencies may arise in MedDRA coding owing to subjectivity. To enhance accuracy, we conducted sampling-based manual reviews. The general flow chart of this study is illustrated in <a href="#pone.0330509.g001" class="usa-link">Fig 1</a>.</p>
<figure class="fig xbox font-sm" id="pone.0330509.g001"><h4 class="obj_head">Fig 1. The flow diagram of selecting and analyzing omeprazole-related ADEs from FAERS database.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367145_pone.0330509.g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d044/12367145/f7a29fc67160/pone.0330509.g001.jpg" loading="lazy" height="501" width="682" alt="Fig 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330509.g001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="sec009"><h3 class="pmc_sec_title">Analysis of omeprazole data</h3>
<p>DPA is a commonly used method in pharmacovigilance studies to assess the association between drug exposure and adverse effects. In this study, DPA was applied to monitor the drug ADR signals. Common metrics used in DPA include Reported Ratio Ratio (ROR), Proportional Reporting Ratio (PRR), Bayesian Confidence Propagation Neural Network (BCPNN), and Empirical Bayesian Geometric Mean (EBGM) (<a href="#pone.0330509.s001" class="usa-link">S1 Fig</a>). These metrics are standard in pharmacovigilance research, particularly when analyzing data from spontaneous reporting systems like the FAERS [<a href="#pone.0330509.ref021" class="usa-link" aria-describedby="pone.0330509.ref021">21</a>–<a href="#pone.0330509.ref023" class="usa-link" aria-describedby="pone.0330509.ref023">23</a>]. The ROR is a highly sensitive measure that can identify even weak associations between drugs and adverse reactions. PRR considers the background reporting rate and eliminates any effects that may be caused by factors such as reporting bias. BCPNN can handle parameter uncertainty and provide more reliable predictions. EBGM reduces bias caused by insufficient or unevenly distributed data, resulting in more reliable estimation results. By using a 2 × 2 table to calculate multiple indicators as described above, the results can be cross-checked, enhancing their reliability (<a href="#pone.0330509.s002" class="usa-link">S1 Table</a>). We selected AEs signals that simultaneously satisfied the criteria of all four algorithms at the PT level. By employing these four metrics, we ensure a multifaceted assessment of the association between omeprazole and AEs, enhancing their reliability, which is a standard practice to increase the confidence in detected signals [<a href="#pone.0330509.ref024" class="usa-link" aria-describedby="pone.0330509.ref024">24</a>]. This multi-indicator approach enhances the reliability of the detected signals, which is particularly crucial in pharmacovigilance studies where data quality and variability may be substantial.</p></section></section><section id="sec010"><h2 class="pmc_sec_title">Results</h2>
<section id="sec011"><h3 class="pmc_sec_title">Basic demographic characteristics</h3>
<p>An analysis of the FEARS database from Q1 2004 to Q4 2023 idenfied 16,800,135 AERs, of which 119,159 were related to omeprazole, involving a total of 403,302 PTs. The highest number of AERs occurred in 2019 with 19,785 reports (16.60% of the total), followed by 2012 with 15,050 reports (12.63%) (<a href="#pone.0330509.g002" class="usa-link">Fig 2</a>). A global distribution of omeprazole AERs revealed that the United States had the highest concentration of AERs, accounting for 55.67% of the total number of reports (<a href="#pone.0330509.s003" class="usa-link">S2 Table</a>). This figure is noteworthy as it reflects the prominence of the United States in the monitoring of adverse drug reactions to omeprazole.</p>
<figure class="fig xbox font-sm" id="pone.0330509.g002"><h4 class="obj_head">Fig 2.  The number of AERs per year since the launch of omeprazole. The X-axis represents the timeline of drug use, and the Y-axis shows the number of reports per quarter.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367145_pone.0330509.g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d044/12367145/12640a2db587/pone.0330509.g002.jpg" loading="lazy" height="332" width="775" alt="Fig 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330509.g002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>Of the reported cases, female patients accounted for 54.51%, slightly more than male patients at 31.29%. The median age of the individuals reporting these AEs was 60.32 years. Additionally, the median weight of individuals reporting these AEs was 77.11 kilograms. Excluding unknown data (26.75%), consumers were the most prevalent reporter type, accounting for 41.08%, followed by physician and lawyer with 10.47% and 8.36%, respectively. Oral administration accounted for the highest proportion among those with a clearly specified route, reaching 81.18%. Among the reported outcomes, excluding those with unclear severity (61.92%), hospitalization were the most frequent consequence, accounting for 23.66%, followed by death, which constituted 6.95% of the total (<a href="#pone.0330509.t001" class="usa-link">Table 1</a>).</p>
<section class="tw xbox font-sm" id="pone.0330509.t001"><h4 class="obj_head">Table 1. Basic demographic characteristics.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">Characteristics</th>
<th align="left" rowspan="1" colspan="1">Number of AER (%)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Sex</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Female</td>
<td align="left" rowspan="1" colspan="1">64957 (54.51)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Male</td>
<td align="left" rowspan="1" colspan="1">37290 (31.29)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Unkown</td>
<td align="left" rowspan="1" colspan="1">16912 (14.19)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Age</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Median (Q1,Q3)</td>
<td align="left" rowspan="1" colspan="1">60.32 (50.00,71.00)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Weight</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Median (Q1,Q3)</td>
<td align="left" rowspan="1" colspan="1">77.11 (64.40,92.50)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Reporter</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Consumer</td>
<td align="left" rowspan="1" colspan="1">48953 (41.08)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Unkown</td>
<td align="left" rowspan="1" colspan="1">31879 (26.75)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Physician</td>
<td align="left" rowspan="1" colspan="1">12472 (10.47)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Lawyer</td>
<td align="left" rowspan="1" colspan="1">9962 (8.36)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Other health-professional</td>
<td align="left" rowspan="1" colspan="1">8141 (6.83)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Pharmacist</td>
<td align="left" rowspan="1" colspan="1">7742 (6.50)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Registered Nurse</td>
<td align="left" rowspan="1" colspan="1">10 (0.01)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Route</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Other</td>
<td align="left" rowspan="1" colspan="1">96739 (81.18)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Oral</td>
<td align="left" rowspan="1" colspan="1">21642 (18.16)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Intravenous</td>
<td align="left" rowspan="1" colspan="1">782 (0.66)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Outcomes</td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Other serious</td>
<td align="left" rowspan="1" colspan="1">59731 (61.92)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Hospitalization</td>
<td align="left" rowspan="1" colspan="1">22822 (23.66)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Death</td>
<td align="left" rowspan="1" colspan="1">6705 (6.95)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Disability</td>
<td align="left" rowspan="1" colspan="1">3478 (3.61)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Life threatening</td>
<td align="left" rowspan="1" colspan="1">2984 (3.09)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Required intervention to Prevent Permanent Impairment/Damage</td>
<td align="left" rowspan="1" colspan="1">447 (0.46)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"> Congenital anomaly</td>
<td align="left" rowspan="1" colspan="1">294 (0.30)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0330509.t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Excluding unknown Indication (14.55%), A analysis of AERs revealed that the five most common indications for omeprazole were GERD (49.46%), dyspepsia (8.34%), peptic ulce, gastric disorder, and gastritis (4.76%, 3.2%, and 2.6%, respectively). The five most frequently observed drugs shared by omeprazole are aspirin, lisinopril, furosemide, atorvastatin, and metoprolol. (<a href="#pone.0330509.t002" class="usa-link">Table 2</a>)</p>
<section class="tw xbox font-sm" id="pone.0330509.t002"><h4 class="obj_head">Table 2. Top five indications and top five concomitant medications of Omeprazole.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1"></th>
<th align="left" rowspan="1" colspan="1">Omeprazole</th>
<th align="left" rowspan="1" colspan="1">N(%)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="6" colspan="1">
<strong>Indications</strong>
</td>
<td align="left" rowspan="1" colspan="1">Gastrooesophageal Reflux Disease</td>
<td align="left" rowspan="1" colspan="1">33920 (49.46)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Unknown Indication</td>
<td align="left" rowspan="1" colspan="1">9980 (14.55)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dyspepsia</td>
<td align="left" rowspan="1" colspan="1">5718 (8.34)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Peptic Ulcer</td>
<td align="left" rowspan="1" colspan="1">3267 (4.76)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Gastric Disorder</td>
<td align="left" rowspan="1" colspan="1">2198 (3.2)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Gastritis</td>
<td align="left" rowspan="1" colspan="1">1782 (2.6)</td>
</tr>
<tr>
<td align="left" rowspan="5" colspan="1">
<strong>Concomitant medications</strong>
</td>
<td align="left" rowspan="1" colspan="1">Aspirin</td>
<td align="left" rowspan="1" colspan="1">13714</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lisinopril</td>
<td align="left" rowspan="1" colspan="1">9916</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">furosemide</td>
<td align="left" rowspan="1" colspan="1">9619</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Atorvastatin</td>
<td align="left" rowspan="1" colspan="1">9547</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Metoprolol</td>
<td align="left" rowspan="1" colspan="1">7508</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0330509.t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec012"><h3 class="pmc_sec_title">Signal analysis of SOCs</h3>
<p>Through statistical analysis of AERs related to omeprazole, we identified 24 SOCs associated with omeprazole-related AERs (<a href="#pone.0330509.t003" class="usa-link">Table 3</a>). Of these, a total of four SOCs were found to meet at least one of the four algorithmic criteria applied. These SOCs were classified as renal and urinary disorders (case reports = 86330; ROR (95% CI) = 15.02(14.9, 15.14); PRR (95% CI) = 12.02(12.02, 12.02); IC (IC025) = 3.46(3.45); and EBGM (EBGM05) = 11.02(10.94)), gastrointestinal disorders (case reports = 66001; ROR (95% CI) = 2.01(1.99, 2.03); PRR (95% CI) = 1.84(1.84, 1.84); IC (IC025) = 0.87(0.86); and EBGM (EBGM05) = 1.83(1.82)), metabolism and nutrition disorders (case reports = 13289; ROR (95% CI) = 1.49(1.46, 1.51); PRR (95% CI) = 1.47(1.44, 1.5); IC (IC025) = 0.55(0.53); and EBGM (EBGM05) = 1.46(1.44)) and endocrine disorders (case reports = 2944; ROR (95% CI) = 2.84(2.74, 2.95); PRR (95% CI) = 2.83(2.72, 2.94); IC (IC025) = 1.48(1.42); and EBGM (EBGM05) = 2.78(2.7)). Furthermore, only renal and urinary disorders met four criteria and were the most common SOC involved in AEs.</p>
<section class="tw xbox font-sm" id="pone.0330509.t003"><h4 class="obj_head">Table 3.  Signal analysis of SOCs.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">SOCs</th>
<th align="left" rowspan="1" colspan="1">Case Reports</th>
<th align="left" rowspan="1" colspan="1">ROR<br>(95% CI)</th>
<th align="left" rowspan="1" colspan="1">PRR<br>(95% CI)</th>
<th align="left" rowspan="1" colspan="1">IC<br>(IC025)</th>
<th align="left" rowspan="1" colspan="1">EBGM<br>(EBGM05)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">renal and urinary disorders</td>
<td align="left" rowspan="1" colspan="1">86330</td>
<td align="left" rowspan="1" colspan="1">15.02 (14.9, 15.14)</td>
<td align="left" rowspan="1" colspan="1">12.02 (12.02, 12.02)</td>
<td align="left" rowspan="1" colspan="1">3.46 (3.45)</td>
<td align="left" rowspan="1" colspan="1">11.02 (10.94)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">gastrointestinal disorders</td>
<td align="left" rowspan="1" colspan="1">66001</td>
<td align="left" rowspan="1" colspan="1">2.01 (1.99, 2.03)</td>
<td align="left" rowspan="1" colspan="1">1.84 (1.84, 1.84)</td>
<td align="left" rowspan="1" colspan="1">0.87 (0.86)</td>
<td align="left" rowspan="1" colspan="1">1.83 (1.82)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">general disorders and administration site conditions</td>
<td align="left" rowspan="1" colspan="1">51267</td>
<td align="left" rowspan="1" colspan="1">0.65 (0.65, 0.66)</td>
<td align="left" rowspan="1" colspan="1">0.7 (0.7, 0.7)</td>
<td align="left" rowspan="1" colspan="1">−0.51 (−0.53)</td>
<td align="left" rowspan="1" colspan="1">0.7 (0.69)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">injury, poisoning and procedural complications</td>
<td align="left" rowspan="1" colspan="1">28540</td>
<td align="left" rowspan="1" colspan="1">0.73 (0.72, 0.74)</td>
<td align="left" rowspan="1" colspan="1">0.75 (0.74, 0.76)</td>
<td align="left" rowspan="1" colspan="1">−0.41 (−0.43)</td>
<td align="left" rowspan="1" colspan="1">0.75 (0.75)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">nervous system disorders</td>
<td align="left" rowspan="1" colspan="1">22937</td>
<td align="left" rowspan="1" colspan="1">0.61 (0.6, 0.62)</td>
<td align="left" rowspan="1" colspan="1">0.63 (0.62, 0.64)</td>
<td align="left" rowspan="1" colspan="1">−0.65 (−0.67)</td>
<td align="left" rowspan="1" colspan="1">0.64 (0.63)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">musculoskeletal and connective tissue disorders</td>
<td align="left" rowspan="1" colspan="1">22367</td>
<td align="left" rowspan="1" colspan="1">1 (0.99, 1.02)</td>
<td align="left" rowspan="1" colspan="1">1 (0.98, 1.02)</td>
<td align="left" rowspan="1" colspan="1">0 (−0.02)</td>
<td align="left" rowspan="1" colspan="1">1 (0.99)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">psychiatric disorders</td>
<td align="left" rowspan="1" colspan="1">16724</td>
<td align="left" rowspan="1" colspan="1">0.67 (0.66, 0.68)</td>
<td align="left" rowspan="1" colspan="1">0.68 (0.67, 0.69)</td>
<td align="left" rowspan="1" colspan="1">−0.54 (−0.57)</td>
<td align="left" rowspan="1" colspan="1">0.69 (0.68)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">investigations</td>
<td align="left" rowspan="1" colspan="1">15557</td>
<td align="left" rowspan="1" colspan="1">0.57 (0.57, 0.58)</td>
<td align="left" rowspan="1" colspan="1">0.59 (0.58, 0.6)</td>
<td align="left" rowspan="1" colspan="1">−0.75 (−0.78)</td>
<td align="left" rowspan="1" colspan="1">0.59 (0.58)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">respiratory, thoracic and mediastinal disorders</td>
<td align="left" rowspan="1" colspan="1">15387</td>
<td align="left" rowspan="1" colspan="1">0.75 (0.74, 0.77)</td>
<td align="left" rowspan="1" colspan="1">0.76 (0.75, 0.78)</td>
<td align="left" rowspan="1" colspan="1">−0.39 (−0.41)</td>
<td align="left" rowspan="1" colspan="1">0.77 (0.75)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">metabolism and nutrition disorders</td>
<td align="left" rowspan="1" colspan="1">13289</td>
<td align="left" rowspan="1" colspan="1">1.49 (1.46, 1.51)</td>
<td align="left" rowspan="1" colspan="1">1.47 (1.44, 1.5)</td>
<td align="left" rowspan="1" colspan="1">0.55 (0.53)</td>
<td align="left" rowspan="1" colspan="1">1.46 (1.44)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">skin and subcutaneous tissue disorders</td>
<td align="left" rowspan="1" colspan="1">12143</td>
<td align="left" rowspan="1" colspan="1">0.52 (0.51, 0.53)</td>
<td align="left" rowspan="1" colspan="1">0.54 (0.53, 0.55)</td>
<td align="left" rowspan="1" colspan="1">−0.89 (−0.92)</td>
<td align="left" rowspan="1" colspan="1">0.54 (0.53)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">infections and infestations</td>
<td align="left" rowspan="1" colspan="1">9441</td>
<td align="left" rowspan="1" colspan="1">0.41 (0.41, 0.42)</td>
<td align="left" rowspan="1" colspan="1">0.43 (0.42, 0.44)</td>
<td align="left" rowspan="1" colspan="1">−1.22 (−1.25)</td>
<td align="left" rowspan="1" colspan="1">0.43 (0.42)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">cardiac disorders</td>
<td align="left" rowspan="1" colspan="1">7801</td>
<td align="left" rowspan="1" colspan="1">0.68 (0.66, 0.69)</td>
<td align="left" rowspan="1" colspan="1">0.68 (0.67, 0.69)</td>
<td align="left" rowspan="1" colspan="1">−0.55 (−0.58)</td>
<td align="left" rowspan="1" colspan="1">0.68 (0.67)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">blood and lymphatic system disorders</td>
<td align="left" rowspan="1" colspan="1">6677</td>
<td align="left" rowspan="1" colspan="1">0.93 (0.91, 0.96)</td>
<td align="left" rowspan="1" colspan="1">0.93 (0.91, 0.95)</td>
<td align="left" rowspan="1" colspan="1">−0.1 (−0.13)</td>
<td align="left" rowspan="1" colspan="1">0.93 (0.92)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">vascular disorders</td>
<td align="left" rowspan="1" colspan="1">5338</td>
<td align="left" rowspan="1" colspan="1">0.57 (0.56, 0.59)</td>
<td align="left" rowspan="1" colspan="1">0.58 (0.57, 0.59)</td>
<td align="left" rowspan="1" colspan="1">−0.79 (−0.82)</td>
<td align="left" rowspan="1" colspan="1">0.58 (0.57)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">neoplasms benign, malignant and unspecified (incl cysts and polyps)</td>
<td align="left" rowspan="1" colspan="1">5036</td>
<td align="left" rowspan="1" colspan="1">0.43 (0.42, 0.44)</td>
<td align="left" rowspan="1" colspan="1">0.44 (0.43, 0.45)</td>
<td align="left" rowspan="1" colspan="1">−1.18 (−1.22)</td>
<td align="left" rowspan="1" colspan="1">0.44 (0.43)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">eye disorders</td>
<td align="left" rowspan="1" colspan="1">4621</td>
<td align="left" rowspan="1" colspan="1">0.54 (0.53, 0.56)</td>
<td align="left" rowspan="1" colspan="1">0.55 (0.54, 0.56)</td>
<td align="left" rowspan="1" colspan="1">−0.86 (−0.9)</td>
<td align="left" rowspan="1" colspan="1">0.55 (0.54)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">immune system disorders</td>
<td align="left" rowspan="1" colspan="1">3489</td>
<td align="left" rowspan="1" colspan="1">0.75 (0.72, 0.77)</td>
<td align="left" rowspan="1" colspan="1">0.75 (0.72, 0.78)</td>
<td align="left" rowspan="1" colspan="1">−0.41 (−0.46)</td>
<td align="left" rowspan="1" colspan="1">0.75 (0.73)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">hepatobiliary disorders</td>
<td align="left" rowspan="1" colspan="1">3144</td>
<td align="left" rowspan="1" colspan="1">0.82 (0.79, 0.84)</td>
<td align="left" rowspan="1" colspan="1">0.82 (0.79, 0.85)</td>
<td align="left" rowspan="1" colspan="1">−0.29 (−0.34)</td>
<td align="left" rowspan="1" colspan="1">0.82 (0.79)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">endocrine disorders</td>
<td align="left" rowspan="1" colspan="1">2944</td>
<td align="left" rowspan="1" colspan="1">2.84 (2.74, 2.95)</td>
<td align="left" rowspan="1" colspan="1">2.83 (2.72, 2.94)</td>
<td align="left" rowspan="1" colspan="1">1.48 (1.42)</td>
<td align="left" rowspan="1" colspan="1">2.78 (2.7)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">ear and labyrinth disorders</td>
<td align="left" rowspan="1" colspan="1">1579</td>
<td align="left" rowspan="1" colspan="1">0.87 (0.82, 0.91)</td>
<td align="left" rowspan="1" colspan="1">0.87 (0.82, 0.92)</td>
<td align="left" rowspan="1" colspan="1">−0.21 (−0.28)</td>
<td align="left" rowspan="1" colspan="1">0.87 (0.83)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">reproductive system and breast disorders</td>
<td align="left" rowspan="1" colspan="1">1441</td>
<td align="left" rowspan="1" colspan="1">0.4 (0.38, 0.43)</td>
<td align="left" rowspan="1" colspan="1">0.41 (0.39, 0.43)</td>
<td align="left" rowspan="1" colspan="1">−1.29 (−1.37)</td>
<td align="left" rowspan="1" colspan="1">0.41 (0.39)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">congenital, familial and genetic disorders</td>
<td align="left" rowspan="1" colspan="1">668</td>
<td align="left" rowspan="1" colspan="1">0.5 (0.47, 0.54)</td>
<td align="left" rowspan="1" colspan="1">0.51 (0.47, 0.55)</td>
<td align="left" rowspan="1" colspan="1">−0.98 (−1.09)</td>
<td align="left" rowspan="1" colspan="1">0.51 (0.48)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">pregnancy, puerperium and perinatal conditions</td>
<td align="left" rowspan="1" colspan="1">581</td>
<td align="left" rowspan="1" colspan="1">0.31 (0.29, 0.34)</td>
<td align="left" rowspan="1" colspan="1">0.31 (0.29, 0.34)</td>
<td align="left" rowspan="1" colspan="1">−1.67 (−1.78)</td>
<td align="left" rowspan="1" colspan="1">0.31 (0.29)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0330509.t003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec013"><h3 class="pmc_sec_title">Signal analysis of PTs</h3>
<p>This study analyzed adverse drug reactions using four indicators and screened a total of 428 PTs that met the four assessment criteria (<a href="#pone.0330509.s004" class="usa-link">S3 Table</a>). We selected the top 20 adverse reactions by ranking according to the number of case reports and categorized by the system (<a href="#pone.0330509.t004" class="usa-link">Table 4</a>).</p>
<section class="tw xbox font-sm" id="pone.0330509.t004"><h4 class="obj_head">Table 4.  PTs by ranking according to the number of case reports.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">SOCs</th>
<th align="left" rowspan="1" colspan="1">PTs</th>
<th align="left" rowspan="1" colspan="1">Case Reports</th>
<th align="left" rowspan="1" colspan="1">ROR(95% CI)</th>
<th align="left" rowspan="1" colspan="1">PRR(95% CI)</th>
<th align="left" rowspan="1" colspan="1">IC(IC025)</th>
<th align="left" rowspan="1" colspan="1">EBGM(EBGM05)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">renal and urinary disorders</td>
<td align="left" rowspan="1" colspan="1">chronic kidney disease</td>
<td align="left" rowspan="1" colspan="1">28639</td>
<td align="left" rowspan="1" colspan="1">87.19 (85.87, 88.54)</td>
<td align="left" rowspan="1" colspan="1">81.07 (79.5, 82.67)</td>
<td align="left" rowspan="1" colspan="1">5.61 (5.59)</td>
<td align="left" rowspan="1" colspan="1">48.77 (48.15)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">acute kidney injury</td>
<td align="left" rowspan="1" colspan="1">15935</td>
<td align="left" rowspan="1" colspan="1">18.54 (18.22, 18.85)</td>
<td align="left" rowspan="1" colspan="1">17.84 (17.49, 18.19)</td>
<td align="left" rowspan="1" colspan="1">3.97 (3.94)</td>
<td align="left" rowspan="1" colspan="1">15.66 (15.44)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">renal failure</td>
<td align="left" rowspan="1" colspan="1">13224</td>
<td align="left" rowspan="1" colspan="1">15.16 (14.89, 15.44)</td>
<td align="left" rowspan="1" colspan="1">14.7 (14.41, 14.99)</td>
<td align="left" rowspan="1" colspan="1">3.72 (3.7)</td>
<td align="left" rowspan="1" colspan="1">13.2 (13)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">end stage renal disease</td>
<td align="left" rowspan="1" colspan="1">8516</td>
<td align="left" rowspan="1" colspan="1">123.18 (119.51, 126.96)</td>
<td align="left" rowspan="1" colspan="1">120.6 (115.96, 125.42)</td>
<td align="left" rowspan="1" colspan="1">5.92 (5.88)</td>
<td align="left" rowspan="1" colspan="1">60.63 (59.12)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">renal injury</td>
<td align="left" rowspan="1" colspan="1">8208</td>
<td align="left" rowspan="1" colspan="1">49.73 (48.46, 51.03)</td>
<td align="left" rowspan="1" colspan="1">48.74 (47.79, 49.7)</td>
<td align="left" rowspan="1" colspan="1">5.13 (5.09)</td>
<td align="left" rowspan="1" colspan="1">34.94 (34.2)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">tubulointerstitial nephritis</td>
<td align="left" rowspan="1" colspan="1">3985</td>
<td align="left" rowspan="1" colspan="1">41.63 (40.16, 43.16)</td>
<td align="left" rowspan="1" colspan="1">41.23 (39.65, 42.88)</td>
<td align="left" rowspan="1" colspan="1">4.95 (4.9)</td>
<td align="left" rowspan="1" colspan="1">30.94 (30.02)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">gastrointestinal disorders</td>
<td align="left" rowspan="1" colspan="1">gastrooesophageal reflux disease</td>
<td align="left" rowspan="1" colspan="1">9705</td>
<td align="left" rowspan="1" colspan="1">20.76 (20.32, 21.22)</td>
<td align="left" rowspan="1" colspan="1">20.29 (19.9, 20.69)</td>
<td align="left" rowspan="1" colspan="1">4.13 (4.1)</td>
<td align="left" rowspan="1" colspan="1">17.5 (17.18)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">dyspepsia</td>
<td align="left" rowspan="1" colspan="1">5882</td>
<td align="left" rowspan="1" colspan="1">9.44 (9.19, 9.7)</td>
<td align="left" rowspan="1" colspan="1">9.32 (9.14, 9.5)</td>
<td align="left" rowspan="1" colspan="1">3.12 (3.09)</td>
<td align="left" rowspan="1" colspan="1">8.72 (8.53)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">rebound acid hypersecretion</td>
<td align="left" rowspan="1" colspan="1">2534</td>
<td align="left" rowspan="1" colspan="1">638.39 (578.97, 703.92)</td>
<td align="left" rowspan="1" colspan="1">634.39 (575.17, 699.71)</td>
<td align="left" rowspan="1" colspan="1">6.67 (6.59)</td>
<td align="left" rowspan="1" colspan="1">101.69 (93.71)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">hyperchlorhydria</td>
<td align="left" rowspan="1" colspan="1">2515</td>
<td align="left" rowspan="1" colspan="1">98.78 (93.7, 104.14)</td>
<td align="left" rowspan="1" colspan="1">98.18 (92.57, 104.13)</td>
<td align="left" rowspan="1" colspan="1">5.77 (5.7)</td>
<td align="left" rowspan="1" colspan="1">54.43 (52.08)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">flatulence</td>
<td align="left" rowspan="1" colspan="1">1257</td>
<td align="left" rowspan="1" colspan="1">3.29 (3.11, 3.48)</td>
<td align="left" rowspan="1" colspan="1">3.28 (3.09, 3.48)</td>
<td align="left" rowspan="1" colspan="1">1.69 (1.61)</td>
<td align="left" rowspan="1" colspan="1">3.22 (3.07)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">blood and lymphatic system disorders</td>
<td align="left" rowspan="1" colspan="1">nephrogenic anaemia</td>
<td align="left" rowspan="1" colspan="1">2914</td>
<td align="left" rowspan="1" colspan="1">229.15 (215.4, 243.78)</td>
<td align="left" rowspan="1" colspan="1">227.5 (214.51, 241.28)</td>
<td align="left" rowspan="1" colspan="1">6.31 (6.24)</td>
<td align="left" rowspan="1" colspan="1">79.18 (75.19)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">injury, poisoning and procedural complications</td>
<td align="left" rowspan="1" colspan="1">intentional product misuse</td>
<td align="left" rowspan="1" colspan="1">2795</td>
<td align="left" rowspan="1" colspan="1">4.8 (4.62, 4.98)</td>
<td align="left" rowspan="1" colspan="1">4.77 (4.59, 4.96)</td>
<td align="left" rowspan="1" colspan="1">2.21 (2.16)</td>
<td align="left" rowspan="1" colspan="1">4.63 (4.48)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">multiple fractures</td>
<td align="left" rowspan="1" colspan="1">1486</td>
<td align="left" rowspan="1" colspan="1">13.02 (12.34, 13.74)</td>
<td align="left" rowspan="1" colspan="1">12.98 (12.24, 13.77)</td>
<td align="left" rowspan="1" colspan="1">3.56 (3.48)</td>
<td align="left" rowspan="1" colspan="1">11.81 (11.29)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">musculoskeletal and connective tissue disorders</td>
<td align="left" rowspan="1" colspan="1">osteoporosis</td>
<td align="left" rowspan="1" colspan="1">2654</td>
<td align="left" rowspan="1" colspan="1">9.66 (9.29, 10.06)</td>
<td align="left" rowspan="1" colspan="1">9.61 (9.24, 9.99)</td>
<td align="left" rowspan="1" colspan="1">3.17 (3.11)</td>
<td align="left" rowspan="1" colspan="1">8.97 (8.68)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">general disorders and administration site conditions</td>
<td align="left" rowspan="1" colspan="1">rebound effect</td>
<td align="left" rowspan="1" colspan="1">2138</td>
<td align="left" rowspan="1" colspan="1">51.43 (48.89, 54.11)</td>
<td align="left" rowspan="1" colspan="1">51.16 (48.24, 54.26)</td>
<td align="left" rowspan="1" colspan="1">5.18 (5.11)</td>
<td align="left" rowspan="1" colspan="1">36.16 (34.66)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">metabolism and nutrition disorders</td>
<td align="left" rowspan="1" colspan="1">hypomagnesaemia</td>
<td align="left" rowspan="1" colspan="1">1911</td>
<td align="left" rowspan="1" colspan="1">24.53 (23.35, 25.77)</td>
<td align="left" rowspan="1" colspan="1">24.42 (23.03, 25.9)</td>
<td align="left" rowspan="1" colspan="1">4.35 (4.28)</td>
<td align="left" rowspan="1" colspan="1">20.46 (19.63)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">hyponatraemia</td>
<td align="left" rowspan="1" colspan="1">1305</td>
<td align="left" rowspan="1" colspan="1">3.32 (3.14, 3.51)</td>
<td align="left" rowspan="1" colspan="1">3.31 (3.12, 3.51)</td>
<td align="left" rowspan="1" colspan="1">1.7 (1.62)</td>
<td align="left" rowspan="1" colspan="1">3.25 (3.1)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">hypocalcaemia</td>
<td align="left" rowspan="1" colspan="1">1220</td>
<td align="left" rowspan="1" colspan="1">10.04 (9.47, 10.65)</td>
<td align="left" rowspan="1" colspan="1">10.01 (9.44, 10.62)</td>
<td align="left" rowspan="1" colspan="1">3.22 (3.14)</td>
<td align="left" rowspan="1" colspan="1">9.32 (8.87)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">endocrine disorders</td>
<td align="left" rowspan="1" colspan="1">hyperparathyroidism secondary</td>
<td align="left" rowspan="1" colspan="1">1489</td>
<td align="left" rowspan="1" colspan="1">203.89 (187.57, 221.63)</td>
<td align="left" rowspan="1" colspan="1">203.14 (187.82, 219.71)</td>
<td align="left" rowspan="1" colspan="1">6.25 (6.15)</td>
<td align="left" rowspan="1" colspan="1">76.03 (70.91)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0330509.t004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec014"><h3 class="pmc_sec_title">Analysis of safety signals in system organ class</h3>
<p>Among all the SOCs, renal and urologic disorders were the only ones to satisfy the four calculation criteria and were also the most prevalent SOC. Consequently, we undertook signal strength calculations for the associated AEs occurring within this SOC. <a href="#pone.0330509.g003" class="usa-link">Fig 3</a> visualizes the signal intensity of AEs using the logarithmically transformed reporting odds ratio (log3ROR, X-axis) and the square root of the chi-square statistic (square root χ², Y-axis). By applying a logarithmic transformation to the ROR, log3ROR renders the data distribution more stable. Higher log3ROR values indicate a stronger association between the drug and the AE. The square root χ² measures the statistical significance of the signal, and the square root transformation compresses the range of the chi-square statistic, making the chart easier to interpret. The size of the dots in the figure represents the number of adverse event reports, and the farther a dot is from the origin, the higher the signal intensity. In this SOC, the top three signal strengths were chronic kidney disease, end stage renal disease and renal injury. We provide explanations of each element in <a href="#pone.0330509.g003" class="usa-link">Fig 3</a> in <a href="#pone.0330509.s005" class="usa-link">S4 Table</a> to facilitate the visualization of <a href="#pone.0330509.g003" class="usa-link">Fig 3</a>.</p>
<figure class="fig xbox font-sm" id="pone.0330509.g003"><h4 class="obj_head">Fig 3. Analysis of safety signals in system organ class.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367145_pone.0330509.g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d044/12367145/60417b4fadfa/pone.0330509.g003.jpg" loading="lazy" height="401" width="682" alt="Fig 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330509.g003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The x-axis displays the log3ROR value, the y-axis represents the square root of the χ<sup>2</sup> value, and the size of the points in the graph reflects the number of adverse reactions reported.</p></figcaption></figure></section></section><section id="sec015"><h2 class="pmc_sec_title">Discussion</h2>
<p>Omeprazole, a commonly prescribed PPI, functions by inhibiting the “proton pump” (H + /K + ATPase) of parietal cells in the stomach, thereby diminishing gastric acid secretion [<a href="#pone.0330509.ref025" class="usa-link" aria-describedby="pone.0330509.ref025">25</a>]. Its widespread use stems from its remarkable acid-suppressing capability. Given its efficacy and safety profile in the majority of cases, off-label utilization of omeprazole is prevalent [<a href="#pone.0330509.ref026" class="usa-link" aria-describedby="pone.0330509.ref026">26</a>]. However, with the increasing usage of medications and the diversity of clinical indications among patients, drug-related adverse reactions and their indications are subject to change, underscoring the need for renewed evaluations. This study analyzed omeprazole-associated AERs and indications based on real-world data in order to assess its safety and efficacy and provide a safety reference for clinical use.</p>
<p>A comprehensive analysis of the FAERS database between the first quarter of 2004 and the fourth quarter of 2023 revealed a total of 119,159 AERs involving omeprazole. Of these, 54.51% were reported by women, whcich was higher than the 31.29% reported by men. While multiple studies have indicated a higher incidence of GERD in males compared to females [<a href="#pone.0330509.ref027" class="usa-link" aria-describedby="pone.0330509.ref027">27</a>,<a href="#pone.0330509.ref028" class="usa-link" aria-describedby="pone.0330509.ref028">28</a>], it is noteworthy that specific research has revealed that females are approximately 40% more likely to exhibit symptoms of GERD than males [<a href="#pone.0330509.ref007" class="usa-link" aria-describedby="pone.0330509.ref007">7</a>]. This phenomenon may account for the tendency of females to use omeprazole more frequently due to the more pervasive impacts of GERD symptoms they experience, subsequently contributing to a higher proportion of AERs associated with omeprazole among females. In terms of reporter types, AERs of omeprazole are primarily sourced from consumers. This phenomenon can be attributed to the drug’s high degree of popularization and ease of access, as well as a notable increase in consumers’ awareness regarding self-monitoring of their health status. Furthermore, the United States is the primary source country for reports, which may be related to the country’s well-established drug regulation and adverse reaction reporting system. This system facilitates the reporting and tracking of adverse reactions to drugs by healthcare organizations, pharmaceutical companies, researchers, and the public.</p>
<p>In our study, we identified the five most frequently co-prescribed medications with omeprazole as aspirin, lisinopril, furosemide, atorvastatin, and metoprolol. Existing literature suggests that omeprazole may enhance the cholesterol-lowering effects of atorvastatin through competitive inhibition of CYP3A4 and CYP2C19 metabolism [<a href="#pone.0330509.ref029" class="usa-link" aria-describedby="pone.0330509.ref029">29</a>]. However, this interaction is associated with potential risks, including an increased incidence of adverse events such as myalgia and liver injury in patients [<a href="#pone.0330509.ref030" class="usa-link" aria-describedby="pone.0330509.ref030">30</a>]. Aspirin is commonly administered concomitantly with omeprazole to mitigate the risk of gastrointestinal bleeding [<a href="#pone.0330509.ref031" class="usa-link" aria-describedby="pone.0330509.ref031">31</a>]. Regarding lisinopril, furosemide, and metoprolol, the current body of literature does not highlight direct interactions with omeprazole. Consequently, future research endeavors could delve deeper into the interactions between omeprazole and these commonly co-prescribed medications, particularly their influence on adverse event profiles.</p>
<p>Our research has revealed that omeprazole has been associated with AEs across a total of 24 SOCs. It is noteworthy that three of these SOCs—the neoplasms benign, malignant and unspecified (incl cysts and polyps), congenital, familial and genetic disorders, and pregnancy, puerperium and perinatal conditions—are not currently mentioned in the existing drug labels, which suggests the potential for unrecognized risks.Among the 24 SOCs, the renal and urinary disorders consistently demonstrated strong positive signals across four distinct signals (case reports = 86330; ROR (95% CI) = 15.02(14.9, 15.14); PRR (95% CI) = 12.02(12.02, 12.02); IC (IC025) = 3.46(3.45); and EBGM (EBGM05) = 11.02(10.94)). Furthermore, the endocrine disorders exhibited strong positive signals in three signals (case reports = 2944; PRR (95% CI) = 2.83(2.72, 2.94); IC (IC025) = 1.48(1.42); and EBGM (EBGM05) = 2.78(2.7)), while the gastrointestinal disorders (case reports = 66001; IC (IC025) = 0.87(0.86)) and metabolism and nutrition disorders (case reports = 13289; IC (IC025) = 0.55(0.53)) also showed strong positive signals in individual signals. In contrast, the signals for the remaining SOCs were not statistically significant.</p>
<p>Our study was centered on the top 20 most frequent PTs, which were extensively distributed across eight distinct SOCs. Notably, PTs associated with the renal and urinary disorders constituted a significant proportion, accounting for up to 30%, closely followed by those related to the gastrointestinal disorders, comprising 25% of the total.</p>
<p>Among the PTs within the renal and urinary disorders, tubulointerstitial nephritis has been explicitly listed in drug product labels, and multiple studies have established a close association between the use of omeprazole and the occurrence of tubulointerstitial nephritis [<a href="#pone.0330509.ref032" class="usa-link" aria-describedby="pone.0330509.ref032">32</a>–<a href="#pone.0330509.ref034" class="usa-link" aria-describedby="pone.0330509.ref034">34</a>]. Although the precise mechanisms underlying this association remain elusive, research has hinted at the activation of interleukin-17, T helper (Th)-1, and Th-17-mediated immune-inflammatory responses, primarily localized to renal tubules with minimal impact on glomeruli [<a href="#pone.0330509.ref035" class="usa-link" aria-describedby="pone.0330509.ref035">35</a>]. Nevertheless, it is noteworthy that other severe renal complications potentially induced by omeprazole, such as chronic kidney disease, acute kidney injury, renal failure, end stage renal disease, and renal impairment, are conspicuously absent from drug product labels. Several studies have unveiled that these adverse effects may stem from omeprazole-induced oxidative stress and cell death in renal tubular cells [<a href="#pone.0330509.ref036" class="usa-link" aria-describedby="pone.0330509.ref036">36</a>]. Furthermore, the resultant renal insufficiency can exacerbate the development of renal anemia [<a href="#pone.0330509.ref037" class="usa-link" aria-describedby="pone.0330509.ref037">37</a>], a pertinent concern in the blood and lymphatic system disorders. While anemia as a general effect is acknowledged in drug product labels, the renal anemia by renal insufficiency is not mentioned.</p>
<p>Within the gastrointestinal disorders, dyspepsia and flatulence, as common PTs, have been explicitly noted in the drug product labels. Prior clinical trials have robustly demonstrated that PPIs, such as omeprazole, can elicit clinical manifestations including dyspepsia and bloating [<a href="#pone.0330509.ref038" class="usa-link" aria-describedby="pone.0330509.ref038">38</a>]. This phenomenon may be underpinned by a marked increase in small intestinal bacterial overgrowth during PPI usage [<a href="#pone.0330509.ref039" class="usa-link" aria-describedby="pone.0330509.ref039">39</a>,<a href="#pone.0330509.ref040" class="usa-link" aria-describedby="pone.0330509.ref040">40</a>], which serves as a pivotal factor contributing to the development of dyspepsia and flatulence [<a href="#pone.0330509.ref041" class="usa-link" aria-describedby="pone.0330509.ref041">41</a>]. Furthermore, although conditions like GERD, rebound acid hypersecretion, and hyperchlorhydria may not be directly mentioned in the drug product labels, omeprazole, being the first-line treatment for GERD, can potentially induce hypergastrinemia during its administration. This, in turn, may precipitate rebound acid hypersecretion and hyperchlorhydria, ultimately exacerbating or triggering GERD [<a href="#pone.0330509.ref017" class="usa-link" aria-describedby="pone.0330509.ref017">17</a>]. Animal studies have shed light on the possible mechanisms underlying this scenario: omeprazole administration may be accompanied by hyperplasia of enterochromaffin-like cells, which is intimately associated with severe hypergastrinemia [<a href="#pone.0330509.ref042" class="usa-link" aria-describedby="pone.0330509.ref042">42</a>]. At last severe hypergastrinemia facilitates the occurrence of rebound acid hypersecretion and hyperchlorhydria [<a href="#pone.0330509.ref043" class="usa-link" aria-describedby="pone.0330509.ref043">43</a>].</p>
<p>In the metabolism and nutrition disorders, the drug product labels of omeprazole has noted the potential association of hypomagnesaemia, hyponatraemia, and hypocalcaemia with its use, and numerous studies have corroborated the induction of these three PTs by omeprazole [<a href="#pone.0330509.ref044" class="usa-link" aria-describedby="pone.0330509.ref044">44</a>–<a href="#pone.0330509.ref046" class="usa-link" aria-describedby="pone.0330509.ref046">46</a>]. The occurrence of hypomagnesaemia may be attributed to the inhibition of gastric acid secretion by proton PPIs, leading to an elevation in luminal pH, which subsequently decreases the activity of TRPM6 and reduces magnesium absorption [<a href="#pone.0330509.ref047" class="usa-link" aria-describedby="pone.0330509.ref047">47</a>]. As for hyponatraemia, its mechanism may be linked to fluid retention resulting from the syndrome of inappropriate antidiuretic hormone secretion induced by omeprazole [<a href="#pone.0330509.ref048" class="usa-link" aria-describedby="pone.0330509.ref048">48</a>]. In the case of hypocalcaemia, omeprazole may interfere with the acidified environment of bone resorption lacunae, causing inactivation of lysosomal enzymes such as tartrate-resistant acid phosphatase (TRAP), thereby slowing down bone matrix degradation and bone resorption processes [<a href="#pone.0330509.ref049" class="usa-link" aria-describedby="pone.0330509.ref049">49</a>]. Notably, although osteoporosis and hyperparathyroidism secondary are not mentioned in the drug product labels of omeprazole, multiple fractures and hypocalcaemia are explicitly noted. However, studies have demonstrated that all four conditions are PTs associated with omeprazole and are interlinked [<a href="#pone.0330509.ref046" class="usa-link" aria-describedby="pone.0330509.ref046">46</a>,<a href="#pone.0330509.ref050" class="usa-link" aria-describedby="pone.0330509.ref050">50</a>–<a href="#pone.0330509.ref052" class="usa-link" aria-describedby="pone.0330509.ref052">52</a>]. Specifically, multiple fractures, osteoporosis, and hyperparathyroidism secondary are closely related to hypocalcaemia. The administration of omeprazole disrupts the acidification of lacunae during the bone resorption process, inhibiting the activity of lysosomal enzymes such as TRAP. This inhibition leads to a reduction in bone matrix degradation and bone resorption, subsequently inducing hypocalcaemia. In turn, hypocalcaemia further promotes the development of hyperparathyroidism secondary, exacerbates osteoporosis, and elevates the risk of fractures [<a href="#pone.0330509.ref049" class="usa-link" aria-describedby="pone.0330509.ref049">49</a>].</p>
<p>In the general disorders and administration site conditions, while rebound effects are not explicitly detailed in the medication’s package insert, they can be regarded as equivalent to the phenomenon of rebound acid hypersecretion. Furthermore, the accessibility of omeprazole, combined with its widespread perception of safety, and lack of significant side effects, contributes to the potential for intentional product misuse, an aspect that is similarly omitted from the drug product labels.</p>
<p>Our study is subject to several limitations. Firstly, a constraint inherent in the FAERS lies in the predominantly self-reported nature of its data, rendering the data susceptible to various external influences and inevitably introducing biases that are difficult to fully eliminate. Furthermore, the significant disparity in the number of reports submitted by consumers versus physician may lead to inaccuracies in the depiction of PTs. Additionally, the lack of detailed information on the severity of PTs in the FAERS database poses a limitation on our capacity to conduct more profound research into PTs. It is also noteworthy that the use of DPA prevents us from establishing a direct causal relationship between drugs and PTs, instead merely revealing statistical correlations between them. Consequently, to more precisely elucidate the relationship between drugs and PTs, conducting more rigorous and prospective studies remains crucial.</p></section><section id="sec016"><h2 class="pmc_sec_title">Conclusion</h2>
<p>This study conducted a comprehensive and meticulous analysis of the indications, concomitant medication use, and AEs associated with omeprazole utilizing the FAERS. The common indications for omeprazole encompass GERD, dyspepsia, peptic ulce, gastric disorder and gastritis. In terms of concomitant medication, omeprazole is frequently administered in combination with aspirin, lisinopril, furosemide, and other drugs. The results of this study revealed that many PTs align with the descriptions provided in the drug product labels. However, it is noteworthy that omeprazole-induced PTs related to the renal and urinary disorders warrant significant attention. These renal-related PTs, such as chronic kidney disease, acute kidney injury, renal failure and end stage renal disease, are largely unmentioned in the drug product labels. This finding underscores the need for healthcare professionals to remain vigilant regarding such risks. Furthermore, the prominent intentional product misuse of omeprazole necessitates the urgent implementation of further regulatory measures.</p></section><section id="sec017"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="pone.0330509.s001"><div class="caption p">
<span>S1 Fig. Commonmetrics.</span><p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12367145/bin/pone.0330509.s001.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0330509.s001.tif</a><sup> (194.3KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0330509.s002"><div class="caption p">
<span>S1 Table. Four grid table.</span><p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12367145/bin/pone.0330509.s002.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330509.s002.docx</a><sup> (14.5KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0330509.s003"><div class="caption p">
<span>S2 Table. A regional analysis of AERs for omeprazole.</span><p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12367145/bin/pone.0330509.s003.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330509.s003.docx</a><sup> (16.2KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0330509.s004"><div class="caption p">
<span>S3 Table. 428 PTs that met the four assessment criteria.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12367145/bin/pone.0330509.s004.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330509.s004.xlsx</a><sup> (50.9KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0330509.s005"><div class="caption p">
<span>S4 Table. Explanations of each element in Fig 3.</span><p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12367145/bin/pone.0330509.s005.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330509.s005.docx</a><sup> (14.6KB, docx) </sup>
</div></div></section></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>FAERS</dt>
<dd><p>FDA Adverse Event Reporting System</p></dd>
<dt>ROR</dt>
<dd><p>ratio of ratios, PRR: proportional reporting ratio</p></dd>
<dt>BCPNN</dt>
<dd><p>Bayesian Confidence Propagation Neural Network</p></dd>
<dt>MGPS</dt>
<dd><p>Multi-Item Gamma Poisson Shrinker</p></dd>
<dt>SOC</dt>
<dd><p>System Organ Class</p></dd>
<dt>PT</dt>
<dd><p>preferred terms</p></dd>
<dt>ADE</dt>
<dd><p>adverse drug event</p></dd>
<dt>AERs</dt>
<dd><p>adverse event reports</p></dd>
<dt>PPI</dt>
<dd><p>proton pump inhibitor</p></dd>
<dt>GERD</dt>
<dd><p>gastroesophageal reflux disease</p></dd>
<dt>H2RAs</dt>
<dd><p>histamine 2 receptor antagonists.</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Data Availability</h2>
<p>This study was performed using the FAERS source that was provided by the FDA. The database used in this study is publicly available on the website of <a href="https://www.fda.gov/drugs/fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-latest-quarterly-data-files" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.fda.gov/drugs/fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-latest-quarterly-data-files</a>.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>The author(s) received no specific funding for this work.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="pone.0330509.ref001">
<span class="label">1.</span><cite>Chan FKL, Leung WK. Peptic-ulcer disease. Lancet. 2002;360(9337):933–41.
</cite> [<a href="https://doi.org/10.1016/s0140-6736(02)11030-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12354485/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Peptic-ulcer%20disease&amp;author=FKL%20Chan&amp;author=WK%20Leung&amp;volume=360&amp;issue=9337&amp;publication_year=2002&amp;pages=933-41&amp;pmid=12354485&amp;doi=10.1016/s0140-6736(02)11030-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref002">
<span class="label">2.</span><cite>Rosenstock SJ, Jørgensen T. Prevalence and incidence of peptic ulcer disease in a Danish County--a prospective cohort study. Gut. 1995;36(6):819–24. doi: 10.1136/gut.36.6.819

</cite> [<a href="https://doi.org/10.1136/gut.36.6.819" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1382615/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7615266/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Prevalence%20and%20incidence%20of%20peptic%20ulcer%20disease%20in%20a%20Danish%20County--a%20prospective%20cohort%20study&amp;author=SJ%20Rosenstock&amp;author=T%20J%C3%B8rgensen&amp;volume=36&amp;issue=6&amp;publication_year=1995&amp;pages=819-24&amp;pmid=7615266&amp;doi=10.1136/gut.36.6.819&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref003">
<span class="label">3.</span><cite>Valle JD.
Peptic Ulcer Disease and Related Disorders. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine [Internet]. 20th ed.
New York, NY: McGraw-Hill Education; 2018.  [cited 2024 Sep 30]. Available from: <a href="http://accessmedicine.mhmedical.com/content.aspx?aid=11600153021160015302" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">accessmedicine.mhmedical.com/content.aspx?aid=11600153021160015302</a>.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Harrison%E2%80%99s%20Principles%20of%20Internal%20Medicine%20%5BInternet%5D&amp;author=JD.%20Valle&amp;author=JL%20Jameson&amp;author=AS%20Fauci&amp;author=DL%20Kasper&amp;author=SL%20Hauser&amp;publication_year=2018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref004">
<span class="label">4.</span><cite>Ramakrishnan K, Salinas RC. Peptic ulcer disease. Am Fam Physician. 2007;76(7):1005–12. 
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/17956071/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20Fam%20Physician&amp;title=Peptic%20ulcer%20disease&amp;author=K%20Ramakrishnan&amp;author=RC%20Salinas&amp;volume=76&amp;issue=7&amp;publication_year=2007&amp;pages=1005-12&amp;pmid=17956071&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref005">
<span class="label">5.</span><cite>Clarrett DM, Hachem C. Gastroesophageal Reflux Disease (GERD). Mo Med [Internet]. 2018.  Jun [cited 2024 Sep 30];115(3). Available from: <a href="https://pubmed.ncbi.nlm.nih.gov/30228725//" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/30228725//</a>.</cite> [<a href="/articles/PMC6140167/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30228725/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mo%20Med&amp;title=Gastroesophageal%20Reflux%20Disease%20(GERD)&amp;author=DM%20Clarrett&amp;author=C%20Hachem&amp;volume=115&amp;issue=3&amp;publication_year=2018&amp;pmid=30228725&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref006">
<span class="label">6.</span><cite>Fock KM, Talley NJ, Fass R, Goh KL, Katelaris P, Hunt R, et al. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol. 2008;23(1):8–22. doi: 10.1111/j.1440-1746.2007.05249.x

</cite> [<a href="https://doi.org/10.1111/j.1440-1746.2007.05249.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18171339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Gastroenterol%20Hepatol&amp;title=Asia-Pacific%20consensus%20on%20the%20management%20of%20gastroesophageal%20reflux%20disease:%20update&amp;author=KM%20Fock&amp;author=NJ%20Talley&amp;author=R%20Fass&amp;author=KL%20Goh&amp;author=P%20Katelaris&amp;volume=23&amp;issue=1&amp;publication_year=2008&amp;pages=8-22&amp;pmid=18171339&amp;doi=10.1111/j.1440-1746.2007.05249.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref007">
<span class="label">7.</span><cite>Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut. 2018;67(3):430–40. doi: 10.1136/gutjnl-2016-313589

</cite> [<a href="https://doi.org/10.1136/gutjnl-2016-313589" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28232473/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Global%20prevalence%20of,%20and%20risk%20factors%20for,%20gastro-oesophageal%20reflux%20symptoms:%20a%20meta-analysis&amp;author=LH%20Eusebi&amp;author=R%20Ratnakumaran&amp;author=Y%20Yuan&amp;author=M%20Solaymani-Dodaran&amp;author=F%20Bazzoli&amp;volume=67&amp;issue=3&amp;publication_year=2018&amp;pages=430-40&amp;pmid=28232473&amp;doi=10.1136/gutjnl-2016-313589&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref008">
<span class="label">8.</span><cite>Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA, et al. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108(5):679–92.
</cite> [<a href="https://doi.org/10.1038/ajg.2013.71" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23567357/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Gastroenterol&amp;title=ACG%20clinical%20guideline:%20evidenced%20based%20approach%20to%20the%20diagnosis%20and%20management%20of%20esophageal%20eosinophilia%20and%20eosinophilic%20esophagitis%20(EoE)&amp;author=ES%20Dellon&amp;author=N%20Gonsalves&amp;author=I%20Hirano&amp;author=GT%20Furuta&amp;author=CA%20Liacouras&amp;volume=108&amp;issue=5&amp;publication_year=2013&amp;pages=679-92&amp;pmid=23567357&amp;doi=10.1038/ajg.2013.71&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref009">
<span class="label">9.</span><cite>Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308–28; quiz 329. doi: 10.1038/ajg.2012.444

</cite> [<a href="https://doi.org/10.1038/ajg.2012.444" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23419381/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Gastroenterol&amp;title=Guidelines%20for%20the%20diagnosis%20and%20management%20of%20gastroesophageal%20reflux%20disease&amp;author=PO%20Katz&amp;author=LB%20Gerson&amp;author=MF%20Vela&amp;volume=108&amp;issue=3&amp;publication_year=2013&amp;pages=308-28&amp;pmid=23419381&amp;doi=10.1038/ajg.2012.444&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref010">
<span class="label">10.</span><cite>Vakil N, Fennerty MB. Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro-oesophageal reflux disease and peptic ulcer disease. Aliment Pharmacol Ther. 2003;18(6):559–68. doi: 10.1046/j.1365-2036.2003.01756.x

</cite> [<a href="https://doi.org/10.1046/j.1365-2036.2003.01756.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12969082/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Aliment%20Pharmacol%20Ther&amp;title=Direct%20comparative%20trials%20of%20the%20efficacy%20of%20proton%20pump%20inhibitors%20in%20the%20management%20of%20gastro-oesophageal%20reflux%20disease%20and%20peptic%20ulcer%20disease&amp;author=N%20Vakil&amp;author=MB%20Fennerty&amp;volume=18&amp;issue=6&amp;publication_year=2003&amp;pages=559-68&amp;pmid=12969082&amp;doi=10.1046/j.1365-2036.2003.01756.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref011">
<span class="label">11.</span><cite>Tighe MP, Andrews E, Liddicoat I, Afzal NA, Hayen A, Beattie RM. Pharmacological treatment of gastro-oesophageal reflux in children. Cochrane Database Syst Rev. 2023;8(8):CD008550. doi: 10.1002/14651858.CD008550.pub3

</cite> [<a href="https://doi.org/10.1002/14651858.CD008550.pub3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10443045/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37635269/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cochrane%20Database%20Syst%20Rev&amp;title=Pharmacological%20treatment%20of%20gastro-oesophageal%20reflux%20in%20children&amp;author=MP%20Tighe&amp;author=E%20Andrews&amp;author=I%20Liddicoat&amp;author=NA%20Afzal&amp;author=A%20Hayen&amp;volume=8&amp;issue=8&amp;publication_year=2023&amp;pmid=37635269&amp;doi=10.1002/14651858.CD008550.pub3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref012">
<span class="label">12.</span><cite>Mari A, Marabotto E, Ribolsi M, Zingone F, Barberio B, Savarino V, et al. Encouraging appropriate use of proton pump inhibitors: existing initiatives and proposals for the future. Expert Rev Clin Pharmacol. 2023;16(10):913–23. doi: 10.1080/17512433.2023.2252327

</cite> [<a href="https://doi.org/10.1080/17512433.2023.2252327" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37632213/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Rev%20Clin%20Pharmacol&amp;title=Encouraging%20appropriate%20use%20of%20proton%20pump%20inhibitors:%20existing%20initiatives%20and%20proposals%20for%20the%20future&amp;author=A%20Mari&amp;author=E%20Marabotto&amp;author=M%20Ribolsi&amp;author=F%20Zingone&amp;author=B%20Barberio&amp;volume=16&amp;issue=10&amp;publication_year=2023&amp;pages=913-23&amp;pmid=37632213&amp;doi=10.1080/17512433.2023.2252327&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref013">
<span class="label">13.</span><cite>Liu Y, Zhu X, Li R, Zhang J, Zhang F. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study. BMJ open [Internet]. 2020.  Nov 26 [cited 2024 Sep 30];10(11). Available from: <a href="https://pubmed.ncbi.nlm.nih.gov/33243802/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/33243802/.</a></cite> [<a href="https://doi.org/10.1136/bmjopen-2020-040473" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7692833/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33243802/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ%20open&amp;title=Proton%20pump%20inhibitor%20utilisation%20and%20potentially%20inappropriate%20prescribing%20analysis:%20insights%20from%20a%20single-centred%20retrospective%20study&amp;author=Y%20Liu&amp;author=X%20Zhu&amp;author=R%20Li&amp;author=J%20Zhang&amp;author=F%20Zhang&amp;volume=10&amp;issue=11&amp;publication_year=2020&amp;pmid=33243802&amp;doi=10.1136/bmjopen-2020-040473&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref014">
<span class="label">14.</span><cite>Bajaj JS, Zadvornova Y, Heuman DM, Hafeezullah M, Hoffmann RG, Sanyal AJ, et al. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am J Gastroenterol. 2009;104(5):1130–4. doi: 10.1038/ajg.2009.80

</cite> [<a href="https://doi.org/10.1038/ajg.2009.80" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19337238/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Gastroenterol&amp;title=Association%20of%20proton%20pump%20inhibitor%20therapy%20with%20spontaneous%20bacterial%20peritonitis%20in%20cirrhotic%20patients%20with%20ascites&amp;author=JS%20Bajaj&amp;author=Y%20Zadvornova&amp;author=DM%20Heuman&amp;author=M%20Hafeezullah&amp;author=RG%20Hoffmann&amp;volume=104&amp;issue=5&amp;publication_year=2009&amp;pages=1130-4&amp;pmid=19337238&amp;doi=10.1038/ajg.2009.80&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref015">
<span class="label">15.</span><cite>Cea Soriano L, Ruigómez A, Johansson S, García Rodríguez LA. Study of the association between hip fracture and acid-suppressive drug use in a UK primary care setting. Pharmacotherapy. 2014;34(6):570–81. doi: 10.1002/phar.1410

</cite> [<a href="https://doi.org/10.1002/phar.1410" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24634193/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacotherapy&amp;title=Study%20of%20the%20association%20between%20hip%20fracture%20and%20acid-suppressive%20drug%20use%20in%20a%20UK%20primary%20care%20setting&amp;author=L%20Cea%20Soriano&amp;author=A%20Ruig%C3%B3mez&amp;author=S%20Johansson&amp;author=LA%20Garc%C3%ADa%20Rodr%C3%ADguez&amp;volume=34&amp;issue=6&amp;publication_year=2014&amp;pages=570-81&amp;pmid=24634193&amp;doi=10.1002/phar.1410&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref016">
<span class="label">16.</span><cite>Wagner SC. Proton pump inhibitors and bone health: what the orthopaedic surgeon needs to know. JBJS Rev. 2018;6(12):e6. doi: 10.2106/JBJS.RVW.18.00029

</cite> [<a href="https://doi.org/10.2106/JBJS.RVW.18.00029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30562209/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JBJS%20Rev&amp;title=Proton%20pump%20inhibitors%20and%20bone%20health:%20what%20the%20orthopaedic%20surgeon%20needs%20to%20know&amp;author=SC%20Wagner&amp;volume=6&amp;issue=12&amp;publication_year=2018&amp;pmid=30562209&amp;doi=10.2106/JBJS.RVW.18.00029&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref017">
<span class="label">17.</span><cite>Xie Y, Bowe B, Li T, Xian H, Yan Y, Al-Aly Z. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury. Kidney Int. 2017;91(6):1482–94. doi: 10.1016/j.kint.2016.12.021

</cite> [<a href="https://doi.org/10.1016/j.kint.2016.12.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28237709/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int&amp;title=Long-term%20kidney%20outcomes%20among%20users%20of%20proton%20pump%20inhibitors%20without%20intervening%20acute%20kidney%20injury&amp;author=Y%20Xie&amp;author=B%20Bowe&amp;author=T%20Li&amp;author=H%20Xian&amp;author=Y%20Yan&amp;volume=91&amp;issue=6&amp;publication_year=2017&amp;pages=1482-94&amp;pmid=28237709&amp;doi=10.1016/j.kint.2016.12.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref018">
<span class="label">18.</span><cite>Lou S, Chen H, Cui Z, Zhang X, Zhu C, Zhou L, et al. Safety evaluation of irinotecan: a real-world disproportionality analysis using FAERS and JADER databases during the time period 2004-2024. Front Pharmacol. 2025;16:1516449.
</cite> [<a href="https://doi.org/10.3389/fphar.2025.1516449" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12184384/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40552159/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pharmacol&amp;title=Safety%20evaluation%20of%20irinotecan:%20a%20real-world%20disproportionality%20analysis%20using%20FAERS%20and%20JADER%20databases%20during%20the%20time%20period%202004-2024&amp;author=S%20Lou&amp;author=H%20Chen&amp;author=Z%20Cui&amp;author=X%20Zhang&amp;author=C%20Zhu&amp;volume=16&amp;publication_year=2025&amp;pages=1516449&amp;pmid=40552159&amp;doi=10.3389/fphar.2025.1516449&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref019">
<span class="label">19.</span><cite>Jiang M, Wu Y, Shah A, Priyanka P, Denny JC, Xu H. Extracting and standardizing medication information in clinical text – the MedEx-UIMA system. AMIA Jt Summits Transl Sci Proc. 2014;2014:37–42.
</cite> [<a href="/articles/PMC4419757/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25954575/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=AMIA%20Jt%20Summits%20Transl%20Sci%20Proc&amp;title=Extracting%20and%20standardizing%20medication%20information%20in%20clinical%20text%20%E2%80%93%20the%20MedEx-UIMA%20system&amp;author=M%20Jiang&amp;author=Y%20Wu&amp;author=A%20Shah&amp;author=P%20Priyanka&amp;author=JC%20Denny&amp;volume=2014&amp;publication_year=2014&amp;pages=37-42&amp;pmid=25954575&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref020">
<span class="label">20.</span><cite>Mozzicato P. Standardised MedDRA queries: their role in signal detection. Drug Saf. 2007;30(7):617–9. doi: 10.2165/00002018-200730070-00009

</cite> [<a href="https://doi.org/10.2165/00002018-200730070-00009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17604415/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Saf&amp;title=Standardised%20MedDRA%20queries:%20their%20role%20in%20signal%20detection&amp;author=P%20Mozzicato&amp;volume=30&amp;issue=7&amp;publication_year=2007&amp;pages=617-9&amp;pmid=17604415&amp;doi=10.2165/00002018-200730070-00009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref021">
<span class="label">21.</span><cite>Zhou C, Peng S, Lin A, Jiang A, Peng Y, Gu T, et al. Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database. EClinicalMedicine. 2023;59:101967. doi: 10.1016/j.eclinm.2023.101967

</cite> [<a href="https://doi.org/10.1016/j.eclinm.2023.101967" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10149185/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37131541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EClinicalMedicine&amp;title=Psychiatric%20disorders%20associated%20with%20immune%20checkpoint%20inhibitors:%20a%20pharmacovigilance%20analysis%20of%20the%20FDA%20Adverse%20Event%20Reporting%20System%20(FAERS)%20database&amp;author=C%20Zhou&amp;author=S%20Peng&amp;author=A%20Lin&amp;author=A%20Jiang&amp;author=Y%20Peng&amp;volume=59&amp;publication_year=2023&amp;pages=101967&amp;pmid=37131541&amp;doi=10.1016/j.eclinm.2023.101967&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref022">
<span class="label">22.</span><cite>Zou SP, Yang HY, Ouyang ML, Cheng Q, Shi X, Sun MH. A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS). BMC Pharmacol Toxicol. 2023;24(1):62. doi: 10.1186/s40360-023-00702-w

</cite> [<a href="https://doi.org/10.1186/s40360-023-00702-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10642055/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37957717/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Pharmacol%20Toxicol&amp;title=A%20disproportionality%20analysis%20of%20adverse%20events%20associated%20to%20pertuzumab%20in%20the%20FDA%20Adverse%20Event%20Reporting%20System%20(FAERS)&amp;author=SP%20Zou&amp;author=HY%20Yang&amp;author=ML%20Ouyang&amp;author=Q%20Cheng&amp;author=X%20Shi&amp;volume=24&amp;issue=1&amp;publication_year=2023&amp;pages=62&amp;pmid=37957717&amp;doi=10.1186/s40360-023-00702-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref023">
<span class="label">23.</span><cite>Yang C, Xu P, Wu T, Fan Y, Li Q, Zhang J, et al. Safety assessment of neurokinin-1 receptor antagonist: real-world adverse event analysis from the FAERS database. Front Pharmacol. 2024;15:1413709.
</cite> [<a href="https://doi.org/10.3389/fphar.2024.1413709" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11321956/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39144621/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pharmacol&amp;title=Safety%20assessment%20of%20neurokinin-1%20receptor%20antagonist:%20real-world%20adverse%20event%20analysis%20from%20the%20FAERS%20database&amp;author=C%20Yang&amp;author=P%20Xu&amp;author=T%20Wu&amp;author=Y%20Fan&amp;author=Q%20Li&amp;volume=15&amp;publication_year=2024&amp;pages=1413709&amp;pmid=39144621&amp;doi=10.3389/fphar.2024.1413709&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref024">
<span class="label">24.</span><cite>Hauben M, Zhou X. Quantitative methods in pharmacovigilance: focus on signal detection. Drug Saf. 2003;26(3):159–86. doi: 10.2165/00002018-200326030-00003

</cite> [<a href="https://doi.org/10.2165/00002018-200326030-00003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12580646/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Saf&amp;title=Quantitative%20methods%20in%20pharmacovigilance:%20focus%20on%20signal%20detection&amp;author=M%20Hauben&amp;author=X%20Zhou&amp;volume=26&amp;issue=3&amp;publication_year=2003&amp;pages=159-86&amp;pmid=12580646&amp;doi=10.2165/00002018-200326030-00003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref025">
<span class="label">25.</span><cite>Clark K, Lam LT, Gibson S, Currow D. The effect of ranitidine versus proton pump inhibitors on gastric secretions: a meta-analysis of randomised control trials. Anaesthesia. 2009;64(6):652–7. doi: 10.1111/j.1365-2044.2008.05861.x

</cite> [<a href="https://doi.org/10.1111/j.1365-2044.2008.05861.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19453319/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anaesthesia&amp;title=The%20effect%20of%20ranitidine%20versus%20proton%20pump%20inhibitors%20on%20gastric%20secretions:%20a%20meta-analysis%20of%20randomised%20control%20trials&amp;author=K%20Clark&amp;author=LT%20Lam&amp;author=S%20Gibson&amp;author=D%20Currow&amp;volume=64&amp;issue=6&amp;publication_year=2009&amp;pages=652-7&amp;pmid=19453319&amp;doi=10.1111/j.1365-2044.2008.05861.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref026">
<span class="label">26.</span><cite>Li W, Zeng S, Yu L-S, Zhou Q. Pharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management. Ther Clin Risk Manag. 2013;9:259–71. doi: 10.2147/TCRM.S43151

</cite> [<a href="https://doi.org/10.2147/TCRM.S43151" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3671798/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23745048/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ther%20Clin%20Risk%20Manag&amp;title=Pharmacokinetic%20drug%20interaction%20profile%20of%20omeprazole%20with%20adverse%20consequences%20and%20clinical%20risk%20management&amp;author=W%20Li&amp;author=S%20Zeng&amp;author=L-S%20Yu&amp;author=Q%20Zhou&amp;volume=9&amp;publication_year=2013&amp;pages=259-71&amp;pmid=23745048&amp;doi=10.2147/TCRM.S43151&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref027">
<span class="label">27.</span><cite>Cook MB, Wild CP, Forman D. A systematic review and meta-analysis of the sex ratio for Barrett’s esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol. 2005;162(11):1050–61. doi: 10.1093/aje/kwi325

</cite> [<a href="https://doi.org/10.1093/aje/kwi325" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16221805/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Epidemiol&amp;title=A%20systematic%20review%20and%20meta-analysis%20of%20the%20sex%20ratio%20for%20Barrett%E2%80%99s%20esophagus,%20erosive%20reflux%20disease,%20and%20nonerosive%20reflux%20disease&amp;author=MB%20Cook&amp;author=CP%20Wild&amp;author=D%20Forman&amp;volume=162&amp;issue=11&amp;publication_year=2005&amp;pages=1050-61&amp;pmid=16221805&amp;doi=10.1093/aje/kwi325&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref028">
<span class="label">28.</span><cite>Asanuma K, Iijima K, Shimosegawa T. Gender difference in gastro-esophageal reflux diseases. World J Gastroenterol [Internet]. 2016.  Jul 2 [cited 2024 Oct 1];22(5). Available from: <a href="https://pubmed.ncbi.nlm.nih.gov/26855539//" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/26855539//</a>.</cite> [<a href="https://doi.org/10.3748/wjg.v22.i5.1800" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4724611/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26855539/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=World%20J%20Gastroenterol&amp;title=Gender%20difference%20in%20gastro-esophageal%20reflux%20diseases&amp;author=K%20Asanuma&amp;author=K%20Iijima&amp;author=T%20Shimosegawa&amp;volume=22&amp;issue=5&amp;publication_year=2016&amp;pmid=26855539&amp;doi=10.3748/wjg.v22.i5.1800&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref029">
<span class="label">29.</span><cite>Barkas F, Elisaf M, Rizos CV, Klouras E, Kostapanos MS, Liberopoulos E. Proton pump inhibitors and statins: a possible interaction that favors low-density lipoprotein cholesterol reduction?. Hippokratia. 2015;19(4):332–7. 
</cite> [<a href="/articles/PMC5033144/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27688698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hippokratia&amp;title=Proton%20pump%20inhibitors%20and%20statins:%20a%20possible%20interaction%20that%20favors%20low-density%20lipoprotein%20cholesterol%20reduction?&amp;author=F%20Barkas&amp;author=M%20Elisaf&amp;author=CV%20Rizos&amp;author=E%20Klouras&amp;author=MS%20Kostapanos&amp;volume=19&amp;issue=4&amp;publication_year=2015&amp;pages=332-7&amp;pmid=27688698&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref030">
<span class="label">30.</span><cite>Elazzazy S, Eziada SS, Zaidan M. Rhabdomyolysis secondary to drug interaction between atorvastatin, omeprazole, and dexamethasone. Int Med Case Rep J. 2012;5:59–61. doi: 10.2147/IMCRJ.S34919

</cite> [<a href="https://doi.org/10.2147/IMCRJ.S34919" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3658256/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23754925/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20Med%20Case%20Rep%20J&amp;title=Rhabdomyolysis%20secondary%20to%20drug%20interaction%20between%20atorvastatin,%20omeprazole,%20and%20dexamethasone&amp;author=S%20Elazzazy&amp;author=SS%20Eziada&amp;author=M%20Zaidan&amp;volume=5&amp;publication_year=2012&amp;pages=59-61&amp;pmid=23754925&amp;doi=10.2147/IMCRJ.S34919&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref031">
<span class="label">31.</span><cite>Li L, Geraghty OC, Mehta Z, Rothwell PM, Oxford Vascular Study. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study. Lancet. 2017;390(10093):490–9. doi: 10.1016/S0140-6736(17)30770-5

</cite> [<a href="https://doi.org/10.1016/S0140-6736(17)30770-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5537194/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28622955/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Age-specific%20risks,%20severity,%20time%20course,%20and%20outcome%20of%20bleeding%20on%20long-term%20antiplatelet%20treatment%20after%20vascular%20events:%20a%20population-based%20cohort%20study&amp;author=L%20Li&amp;author=OC%20Geraghty&amp;author=Z%20Mehta&amp;author=PM%20Rothwell&amp;author=Study%20Oxford%20Vascular&amp;volume=390&amp;issue=10093&amp;publication_year=2017&amp;pages=490-9&amp;pmid=28622955&amp;doi=10.1016/S0140-6736(17)30770-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref032">
<span class="label">32.</span><cite>Muriithi AK, Leung N, Valeri AM, Cornell LD, Sethi S, Fidler ME, et al. Clinical characteristics, causes and outcomes of acute interstitial nephritis in the elderly. Kidney Int. 2015;87(2):458–64. doi: 10.1038/ki.2014.294

</cite> [<a href="https://doi.org/10.1038/ki.2014.294" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25185078/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int&amp;title=Clinical%20characteristics,%20causes%20and%20outcomes%20of%20acute%20interstitial%20nephritis%20in%20the%20elderly&amp;author=AK%20Muriithi&amp;author=N%20Leung&amp;author=AM%20Valeri&amp;author=LD%20Cornell&amp;author=S%20Sethi&amp;volume=87&amp;issue=2&amp;publication_year=2015&amp;pages=458-64&amp;pmid=25185078&amp;doi=10.1038/ki.2014.294&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref033">
<span class="label">33.</span><cite>Ni N, Moeckel GW, Kumar C. Late-onset omeprazole-associated acute interstitial nephritis. J Am Geriatr Soc. 2010;58(12):2443–4. doi: 10.1111/j.1532-5415.2010.03194.x

</cite> [<a href="https://doi.org/10.1111/j.1532-5415.2010.03194.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21143456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Geriatr%20Soc&amp;title=Late-onset%20omeprazole-associated%20acute%20interstitial%20nephritis&amp;author=N%20Ni&amp;author=GW%20Moeckel&amp;author=C%20Kumar&amp;volume=58&amp;issue=12&amp;publication_year=2010&amp;pages=2443-4&amp;pmid=21143456&amp;doi=10.1111/j.1532-5415.2010.03194.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref034">
<span class="label">34.</span><cite>Torlot FJA, Whitehead DJ. Acute interstitial nephritis caused by two different proton pump inhibitors. Br J Hosp Med (Lond). 2016;77(1):50–1. doi: 10.12968/hmed.2016.77.1.50

</cite> [<a href="https://doi.org/10.12968/hmed.2016.77.1.50" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26903459/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Hosp%20Med%20(Lond)&amp;title=Acute%20interstitial%20nephritis%20caused%20by%20two%20different%20proton%20pump%20inhibitors&amp;author=FJA%20Torlot&amp;author=DJ%20Whitehead&amp;volume=77&amp;issue=1&amp;publication_year=2016&amp;pages=50-1&amp;pmid=26903459&amp;doi=10.12968/hmed.2016.77.1.50&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref035">
<span class="label">35.</span><cite>Berney-Meyer L, Hung N, Slatter T, Schollum JB, Kitching AR, Walker RJ. Omeprazole-induced acute interstitial nephritis: a possible Th1-Th17-mediated injury?. Nephrology (Carlton). 2014;19(6):359–65. doi: 10.1111/nep.12226

</cite> [<a href="https://doi.org/10.1111/nep.12226" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24629073/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nephrology%20(Carlton)&amp;title=Omeprazole-induced%20acute%20interstitial%20nephritis:%20a%20possible%20Th1-Th17-mediated%20injury?&amp;author=L%20Berney-Meyer&amp;author=N%20Hung&amp;author=T%20Slatter&amp;author=JB%20Schollum&amp;author=AR%20Kitching&amp;volume=19&amp;issue=6&amp;publication_year=2014&amp;pages=359-65&amp;pmid=24629073&amp;doi=10.1111/nep.12226&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref036">
<span class="label">36.</span><cite>Fontecha-Barriuso M, Martín-Sanchez D, Martinez-Moreno JM, Cardenas-Villacres D, Carrasco S, Sanchez-Niño MD, et al. Molecular pathways driving omeprazole nephrotoxicity. Redox Biol. 2020;32:101464. doi: 10.1016/j.redox.2020.101464

</cite> [<a href="https://doi.org/10.1016/j.redox.2020.101464" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7038587/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32092686/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Redox%20Biol&amp;title=Molecular%20pathways%20driving%20omeprazole%20nephrotoxicity&amp;author=M%20Fontecha-Barriuso&amp;author=D%20Mart%C3%ADn-Sanchez&amp;author=JM%20Martinez-Moreno&amp;author=D%20Cardenas-Villacres&amp;author=S%20Carrasco&amp;volume=32&amp;publication_year=2020&amp;pages=101464&amp;pmid=32092686&amp;doi=10.1016/j.redox.2020.101464&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref037">
<span class="label">37.</span><cite>Mikhail A, Brown C, Williams JA, Mathrani V, Shrivastava R, Evans J, et al. Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease. BMC Nephrol. 2017;18(1):345. doi: 10.1186/s12882-017-0688-1

</cite> [<a href="https://doi.org/10.1186/s12882-017-0688-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5709852/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29191165/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Nephrol&amp;title=Renal%20association%20clinical%20practice%20guideline%20on%20Anaemia%20of%20Chronic%20Kidney%20Disease&amp;author=A%20Mikhail&amp;author=C%20Brown&amp;author=JA%20Williams&amp;author=V%20Mathrani&amp;author=R%20Shrivastava&amp;volume=18&amp;issue=1&amp;publication_year=2017&amp;pages=345&amp;pmid=29191165&amp;doi=10.1186/s12882-017-0688-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref038">
<span class="label">38.</span><cite>Marzio L, Biasco G, Cifani F, DeFanis C, Falcucci M, Ferrini G, et al. Short- and long-term omeprazole for the treatment and prevention of duodenal ulcer, and effect on Helicobacter pylori. Am J Gastroenterol. 1995;90(12):2172–6. 
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/8540510/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Gastroenterol&amp;title=Short-%20and%20long-term%20omeprazole%20for%20the%20treatment%20and%20prevention%20of%20duodenal%20ulcer,%20and%20effect%20on%20Helicobacter%20pylori&amp;author=L%20Marzio&amp;author=G%20Biasco&amp;author=F%20Cifani&amp;author=C%20DeFanis&amp;author=M%20Falcucci&amp;volume=90&amp;issue=12&amp;publication_year=1995&amp;pages=2172-6&amp;pmid=8540510&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref039">
<span class="label">39.</span><cite>Ratuapli SK, Ellington TG, O’Neill MT, Umar SB, Harris LA, Foxx-Orenstein AE. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth. Am J Gastroenterol. 2012;107(5):730–5.
</cite> [<a href="https://doi.org/10.1038/ajg.2012.4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22334250/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Gastroenterol&amp;title=Proton%20pump%20inhibitor%20therapy%20use%20does%20not%20predispose%20to%20small%20intestinal%20bacterial%20overgrowth&amp;author=SK%20Ratuapli&amp;author=TG%20Ellington&amp;author=MT%20O%E2%80%99Neill&amp;author=SB%20Umar&amp;author=LA%20Harris&amp;volume=107&amp;issue=5&amp;publication_year=2012&amp;pages=730-5&amp;pmid=22334250&amp;doi=10.1038/ajg.2012.4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref040">
<span class="label">40.</span><cite>Lombardo L, Foti M, Ruggia O, Chiecchio A. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol. 2010;8(6):504–8.
</cite> [<a href="https://doi.org/10.1016/j.cgh.2009.12.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20060064/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Gastroenterol%20Hepatol&amp;title=Increased%20incidence%20of%20small%20intestinal%20bacterial%20overgrowth%20during%20proton%20pump%20inhibitor%20therapy&amp;author=L%20Lombardo&amp;author=M%20Foti&amp;author=O%20Ruggia&amp;author=A%20Chiecchio&amp;volume=8&amp;issue=6&amp;publication_year=2010&amp;pages=504-8&amp;pmid=20060064&amp;doi=10.1016/j.cgh.2009.12.022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref041">
<span class="label">41.</span><cite>Singh VV, Toskes PP. Small bowel bacterial overgrowth: presentation, diagnosis, and treatment. Curr Treat Options Gastroenterol. 2004;7(1):19–28.
</cite> [<a href="https://doi.org/10.1007/s11938-004-0022-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14723835/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Treat%20Options%20Gastroenterol&amp;title=Small%20bowel%20bacterial%20overgrowth:%20presentation,%20diagnosis,%20and%20treatment&amp;author=VV%20Singh&amp;author=PP%20Toskes&amp;volume=7&amp;issue=1&amp;publication_year=2004&amp;pages=19-28&amp;pmid=14723835&amp;doi=10.1007/s11938-004-0022-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref042">
<span class="label">42.</span><cite>Driman DK, Wright C, Tougas G, Riddell RH. Omeprazole produces parietal cell hypertrophy and hyperplasia in humans. Dig Dis Sci. 1996;41(10):2039–47. doi: 10.1007/BF02093608

</cite> [<a href="https://doi.org/10.1007/BF02093608" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8888719/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dig%20Dis%20Sci&amp;title=Omeprazole%20produces%20parietal%20cell%20hypertrophy%20and%20hyperplasia%20in%20humans&amp;author=DK%20Driman&amp;author=C%20Wright&amp;author=G%20Tougas&amp;author=RH%20Riddell&amp;volume=41&amp;issue=10&amp;publication_year=1996&amp;pages=2039-47&amp;pmid=8888719&amp;doi=10.1007/BF02093608&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref043">
<span class="label">43.</span><cite>Solcia E, Rindi G, Havu N, Elm G. Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole. Scand J Gastroenterol Suppl. 1989;166:129–37.
</cite> [<a href="https://doi.org/10.3109/00365528909091260" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2513643/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scand%20J%20Gastroenterol%20Suppl&amp;title=Qualitative%20studies%20of%20gastric%20endocrine%20cells%20in%20patients%20treated%20long-term%20with%20omeprazole&amp;author=E%20Solcia&amp;author=G%20Rindi&amp;author=N%20Havu&amp;author=G%20Elm&amp;volume=166&amp;publication_year=1989&amp;pages=129-37&amp;pmid=2513643&amp;doi=10.3109/00365528909091260&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref044">
<span class="label">44.</span><cite>Buon M, Gaillard C, Martin J, Fedrizzi S, Mosquet B, Coquerel A, et al. Risk of proton pump inhibitor-induced mild hyponatremia in older adults. J Am Geriatr Soc. 2013;61(11):2052–4. doi: 10.1111/jgs.12534

</cite> [<a href="https://doi.org/10.1111/jgs.12534" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24219214/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Geriatr%20Soc&amp;title=Risk%20of%20proton%20pump%20inhibitor-induced%20mild%20hyponatremia%20in%20older%20adults&amp;author=M%20Buon&amp;author=C%20Gaillard&amp;author=J%20Martin&amp;author=S%20Fedrizzi&amp;author=B%20Mosquet&amp;volume=61&amp;issue=11&amp;publication_year=2013&amp;pages=2052-4&amp;pmid=24219214&amp;doi=10.1111/jgs.12534&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref045">
<span class="label">45.</span><cite>Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, Srivali N, Edmonds PJ, Ungprasert P, et al. Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies. Ren Fail. 2015;37(7):1237–41. doi: 10.3109/0886022X.2015.1057800

</cite> [<a href="https://doi.org/10.3109/0886022X.2015.1057800" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26108134/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ren%20Fail&amp;title=Proton%20pump%20inhibitors%20linked%20to%20hypomagnesemia:%20a%20systematic%20review%20and%20meta-analysis%20of%20observational%20studies&amp;author=W%20Cheungpasitporn&amp;author=C%20Thongprayoon&amp;author=W%20Kittanamongkolchai&amp;author=N%20Srivali&amp;author=PJ%20Edmonds&amp;volume=37&amp;issue=7&amp;publication_year=2015&amp;pages=1237-41&amp;pmid=26108134&amp;doi=10.3109/0886022X.2015.1057800&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref046">
<span class="label">46.</span><cite>Isse N, Hashimoto M. Republished: omeprazole-induced hypomagnesaemia, causing renal tubular acidosis with hypokalaemia, hypocalcaemia, hyperlactacidaemia and hyperammonaemia. Drug Ther Bull. 2021;59(4):60–3. doi: 10.1136/dtb.2021.235385rep

</cite> [<a href="https://doi.org/10.1136/dtb.2021.235385rep" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33766923/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Ther%20Bull&amp;title=Republished:%20omeprazole-induced%20hypomagnesaemia,%20causing%20renal%20tubular%20acidosis%20with%20hypokalaemia,%20hypocalcaemia,%20hyperlactacidaemia%20and%20hyperammonaemia&amp;author=N%20Isse&amp;author=M%20Hashimoto&amp;volume=59&amp;issue=4&amp;publication_year=2021&amp;pages=60-3&amp;pmid=33766923&amp;doi=10.1136/dtb.2021.235385rep&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref047">
<span class="label">47.</span><cite>William JH, Danziger J. Proton-pump inhibitor-induced hypomagnesemia: current research and proposed mechanisms. World J Nephrol. 2016.  Mar 6;5(2):152–7.
</cite> [<a href="https://doi.org/10.5527/wjn.v5.i2.152" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4777786/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26981439/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=World%20J%20Nephrol&amp;title=Proton-pump%20inhibitor-induced%20hypomagnesemia:%20current%20research%20and%20proposed%20mechanisms&amp;author=JH%20William&amp;author=J%20Danziger&amp;volume=5&amp;issue=2&amp;publication_year=2016&amp;pages=152-7&amp;pmid=26981439&amp;doi=10.5527/wjn.v5.i2.152&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref048">
<span class="label">48.</span><cite>Brewster UC, Perazella MA. Proton pump inhibitors and the kidney: critical review. Clin Nephrol. 2007;68(2):65–72. doi: 10.5414/cnp68065

</cite> [<a href="https://doi.org/10.5414/cnp68065" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17722704/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Nephrol&amp;title=Proton%20pump%20inhibitors%20and%20the%20kidney:%20critical%20review&amp;author=UC%20Brewster&amp;author=MA%20Perazella&amp;volume=68&amp;issue=2&amp;publication_year=2007&amp;pages=65-72&amp;pmid=17722704&amp;doi=10.5414/cnp68065&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref049">
<span class="label">49.</span><cite>Mizunashi K, Furukawa Y, Katano K, Abe K. Effect of omeprazole, an inhibitor of H+,K(+)-ATPase, on bone resorption in humans. Calcif Tissue Int. 1993.  Jul;53(1):21–5.
</cite> [<a href="https://doi.org/10.1007/BF01352010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8102318/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Calcif%20Tissue%20Int&amp;title=Effect%20of%20omeprazole,%20an%20inhibitor%20of%20H+,K(+)-ATPase,%20on%20bone%20resorption%20in%20humans&amp;author=K%20Mizunashi&amp;author=Y%20Furukawa&amp;author=K%20Katano&amp;author=K%20Abe&amp;volume=53&amp;issue=1&amp;publication_year=1993&amp;pages=21-5&amp;pmid=8102318&amp;doi=10.1007/BF01352010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref050">
<span class="label">50.</span><cite>Park JH, Lee J, Yu SY, Jung JH, Han K, Kim DH, et al. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease. BMC Geriatr. 2020;20(1):407. doi: 10.1186/s12877-020-01794-3

</cite> [<a href="https://doi.org/10.1186/s12877-020-01794-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7565339/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33059626/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Geriatr&amp;title=Comparing%20proton%20pump%20inhibitors%20with%20histamin-2%20receptor%20blockers%20regarding%20the%20risk%20of%20osteoporotic%20fractures:%20a%20nested%20case-control%20study%20of%20more%20than%20350,000%20Korean%20patients%20with%20GERD%20and%20peptic%20ulcer%20disease&amp;author=JH%20Park&amp;author=J%20Lee&amp;author=SY%20Yu&amp;author=JH%20Jung&amp;author=K%20Han&amp;volume=20&amp;issue=1&amp;publication_year=2020&amp;pages=407&amp;pmid=33059626&amp;doi=10.1186/s12877-020-01794-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref051">
<span class="label">51.</span><cite>Staines KA, Myers K, Little K, Ralston SH, Farquharson C. Proton pump inhibitors inhibit PHOSPHO1 activity and matrix mineralisation in vitro. Calcif Tissue Int. 2021;109(6):696–705. doi: 10.1007/s00223-021-00882-9

</cite> [<a href="https://doi.org/10.1007/s00223-021-00882-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8531085/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34213594/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Calcif%20Tissue%20Int&amp;title=Proton%20pump%20inhibitors%20inhibit%20PHOSPHO1%20activity%20and%20matrix%20mineralisation%20in%20vitro&amp;author=KA%20Staines&amp;author=K%20Myers&amp;author=K%20Little&amp;author=SH%20Ralston&amp;author=C%20Farquharson&amp;volume=109&amp;issue=6&amp;publication_year=2021&amp;pages=696-705&amp;pmid=34213594&amp;doi=10.1007/s00223-021-00882-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330509.ref052">
<span class="label">52.</span><cite>Zhou B, Huang Y, Li H, Sun W, Liu J. Proton-pump inhibitors and risk of fractures: an update meta-analysis. Osteoporos Int. 2016;27(1):339–47. doi: 10.1007/s00198-015-3365-x

</cite> [<a href="https://doi.org/10.1007/s00198-015-3365-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26462494/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Osteoporos%20Int&amp;title=Proton-pump%20inhibitors%20and%20risk%20of%20fractures:%20an%20update%20meta-analysis&amp;author=B%20Zhou&amp;author=Y%20Huang&amp;author=H%20Li&amp;author=W%20Sun&amp;author=J%20Liu&amp;volume=27&amp;issue=1&amp;publication_year=2016&amp;pages=339-47&amp;pmid=26462494&amp;doi=10.1007/s00198-015-3365-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>S1 Fig. Commonmetrics.</span><p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12367145/bin/pone.0330509.s001.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0330509.s001.tif</a><sup> (194.3KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p">
<span>S1 Table. Four grid table.</span><p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12367145/bin/pone.0330509.s002.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330509.s002.docx</a><sup> (14.5KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p">
<span>S2 Table. A regional analysis of AERs for omeprazole.</span><p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12367145/bin/pone.0330509.s003.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330509.s003.docx</a><sup> (16.2KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="caption p">
<span>S3 Table. 428 PTs that met the four assessment criteria.</span><p>(XLSX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12367145/bin/pone.0330509.s004.xlsx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330509.s004.xlsx</a><sup> (50.9KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="caption p">
<span>S4 Table. Explanations of each element in Fig 3.</span><p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12367145/bin/pone.0330509.s005.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330509.s005.docx</a><sup> (14.6KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>This study was performed using the FAERS source that was provided by the FDA. The database used in this study is publicly available on the website of <a href="https://www.fda.gov/drugs/fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-latest-quarterly-data-files" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.fda.gov/drugs/fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-latest-quarterly-data-files</a>.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from PLOS One are provided here courtesy of <strong>PLOS</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1371/journal.pone.0330509"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/pone.0330509.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (590.0 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12367145/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12367145/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12367145%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367145/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12367145/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12367145/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40834017/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12367145/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40834017/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12367145/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12367145/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="rumXMEkLuFPn2IvaUET7sWSEvCeCmJTYX9xwfg4M7jA7oAtmRhsLVWmVIy2yI1Gr">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
